Toxicology Letters

Human genome mapping and sequencing: perspectives for toxicology
pp. 1-1(1)
Author: Weissenbach J.

Micronutrients & degenerative diseases of aging
pp. 1-1(1)
Author: Ames B.N.

Chemically-induced apoptosis: P21 and P53 as determinants of enterotoxin activity
pp. 1-1(1)
Authors: Pritchard D.M.; Jackman A.; Potten C.S.; Hickman J.A.

Recent advances in molecular mechanisms of nephrotoxicity
pp. 1-2(2)
Author: Endou H.

Healthy volunteer studies in toxicology
pp. 2-2(1)
Authors: Meulenbelt J.; Mensinga T.T.; Kortboyer J.M.; de Vries I.

Transgenic animal models are an appropriate alternative to the second species in testing for carcinogenicity of pharmaceuticals (for)
pp. 2-2(1)
Author: Van Cauteren H.

Transgenic animal models are an appropriate alternative to the second species in testing for carcinogenicity of pharmaceuticals (for)
pp. 2-2(1)
Author: Goodman J.I.

Biomarkers are of little practical value in cancer epidemiology (against)
pp. 2-2(1)
Author: Tannenbaum S.R.

Meta-analysis in chemical toxicity is more often abused than used (for)
pp. 3-3(1)
Author: Caporaso N.

Meta-analysis in chemical toxicity is more often abused than used (against)
pp. 3-3(1)
Author: Brennan P.J.

Telomerase enzyme activation and human cell immortalization
pp. 3-3(1)
Authors: Meyerson M.; Counter C.; Eaton E.N.; Steiner P.; Beijersbergen R.; Caddle S.D.; Hahn W.; Dessain S.; Ellisen L.; Haber D.; Weinberg R.A.

DNA repair in human diseases and aging
pp. 3-4(2)
Author: Bohr V.A.

O⁶-alkylguanine-DNA alkyltransferase: influence on susceptibility to the genetic effects of alkylating agents
pp. 4-4(1)
Author: Kyrtopoulos S.A.

Inhibition of the cAMP signalling cascade via the cannabinoid receptors: a putative mechanism of immune modulation by cannabinoid compounds
pp. 4-4(1)
Author: Kaminski N.E.

Transient brain ischemia- and bacterial endotoxin (LPS)-induced glial iNOS expression and no-induced neuronal apoptosis
pp. 4-4(1)
Author: Nomura Y.

Epigenetic toxicology as toxicant-induced changes in intracellular signalling leading to altered gap junctional communication
pp. 4-5(2)
Author: Trosko J.E.

Down-regulation of protein kinase C: a potential mechanism for 2-amino-3-methylimidazo[4,5-f]quinolone-mediated immunosuppression
pp. 5-5(1)
Authors: Yang K.H.; Lee Y.W.; Jeon Y.J.

PPAR activation and its consequences in humans
pp. 5-5(1)
Author: Bar-Tana J.

PPAR-regulated growth responses and their importance to hepatocarcinogenesis
pp. 5-5(1)
Authors: James N.H.; Woodyatt N.J.; Macdonald N.; Rolfe M.; Hasmall S.C.; Holden P.R.; Tugwood J.D.; Roberts R.A.

Mechanistic relevance of peroxisome proliferation to human cancer risk assessment
pp. 5-6(2)
Author: Reddy J.K.

Recent discoveries in pharmacokinetics of drugs of abuse
pp. 6-6(1)
Author: Cone E.J.

Recent developments in analytical toxicology, for better of worse
pp. 6-6(1)
Author: de Zeeuw R.A.

Applications of alternative matrices (hair, saliva, sweat ...) in forensic toxicology
pp. 6-6(1)
Authors: Kintz P.; Ludes B.

Life and death in the genesis of the tumour cell
pp. 7-7(1)
Author: Harrison D.J.

Role of caspases as the executioners of apoptosis
pp. 7-7(1)
Author: Cohen G.M.

The APO-1 (FAS/CD95)-mediated death-signal and immune diseases
pp. 7-7(1)
Author: Krammer P.H.

Intracellular ATP: a switch in the decision between apoptosis and necrosis
pp. 7-8(2)
Author: Nicotera P.

Recent advances in understanding the molecular basis of polymorphisms of cytochrome P450 enzymes
pp. 8-8(1)
Author: Daly A.K.

An update on polymorphisms of the phase II enzymes of xenobiotic metabolism
pp. 8-8(1)
Author: Board P.

Functional consequences of polymorphisms of xenobiotic metabolising enzymes
pp. 8-8(1)
Author: Ingelman-Sundberg M.

Genetically-engineered animals in the study of cytochromes P450 and carcinogenesis
pp. 8-9(2)
Author: Gonzalez F.J.

Gene-environment interaction in occupational toxicology
pp. 9-9(1)
Author: Vainio H.

Polymorphic CYP genes and disease predisposition - what have the studies shown so far?
pp. 9-9(1)
Author: Watanabe M.

Polymorphisms in xenobiotic conjugation and disease predisposition
pp. 9-10(2)
Authors: Brockmoller J.; Cascorbi L.; Kerb R.; Roots L.

Mechanism of action of clostridial neurotoxins
pp. 10-10(1)
Authors: Montecucco C.; Pellizzari R.; Rossetto O.; Schiavo G.; Tonello F.

Structure and function of nicotinic acetylcholine receptor ligands
pp. 10-10(1)
Authors: Servent D.; Antil S.; Bertrand D.; Rochette S.; Rivaille P.; Jolivet M.; Menez A.

Neurotoxicological implications of the catalytic and non-catalytic functions of acetylcholinesterase
pp. 10-10(1)
Author: Soreq H.

Ion gated neuronal nicotinic receptors modulate synaptic function in the hippocampus
pp. 10-11(2)
Author: Albuquerque E.X.

Epidemiology of cancer: global patterns and trends
pp. 11-11(1)
Author: Parkin D.M.

Tumor suppressor genes: at the crossroad of molecular carcinogenesis and molecular epidemiology
pp. 11-11(1)
Author: Harris C.C.

Carcinogenicity of metal compounds
pp. 11-12(2)
Authors: Hartwig A.; Asmusz M.; Dally H.; Hartmann M.

Carcinogenic risk assessment. Can we harmonise?
pp. 12-12(1)
Authors: Di Marco P.N.; Priestly B.G.; Buckett K.J.

Immunotoxicology assessment in the pharmaceutical industry
pp. 12-12(1)
Authors: Dean J.H.; Remandet B.

Testing strategies in immunotoxicology
pp. 12-12(1)
Author: Pallardy M.

Risk assessment and immunotoxicity
pp. 12-13(2)
Authors: Van Loveren H.; Garssen J.; Slob W.; Vandebriel R.J.; de Jong W.H.; Vos J.G.

What are the perspectives for regulation in immunotoxicology?
pp. 13-13(1)
Author: Hastings K.L.

Chemical-induced activation of nuclear transcription factors and their regulation of cytokine secretion
pp. 13-13(1)
Author: Luster M.I.

Cytokines and irritant contact dermatitis
pp. 13-13(1)
Author: Corsini E.

Glial function and modulation of CNS immune responses
pp. 13-13(1)
Author: Aschner M.

Role of inflammatory cytokines in hepatic and pulmonary toxicity
pp. 13-14(2)
Authors: Laskin D.L.; Heck D.E.; Laskin J.D.

Carbon monoxide and nitric oxide control interleukin-1 production and release in rat brain
pp. 14-14(1)
Authors: Navarra P.; Preziosi P.

Legal background and general principles of risk assessment
pp. 14-14(1)
Author: Hansen B.G.

Science-based criteria, rules and methods of risk assessment
pp. 14-14(1)
Author: van Leeuwen C.J.

Computer fate models and field monitoring as key elements in environmental risk assessment
pp. 15-15(1)
Author: Schroeder F.R.

Assessment factors in human health risk assessment
pp. 15-15(1)
Author: Fedtke N.

Special aspects of endocrine modulators in human and environmental risk assessment of existing chemicals
pp. 15-15(1)
Author: Bolt H.M.

Risk assessment for the marine environment
pp. 15-15(1)
Author: Lecloux A.

Introduction: allergy, asthma and the environment
pp. 15-16(2)
Author: Kimber I.

Epidemiological analyses of the relationship between environmental pollution and asthma
pp. 16-16(1)
Authors: Keil U.; Duhme H.; Weiland S.K.

Experimental assessment of the influence of atmospheric pollutants on respiratory diseases
pp. 16-16(1)
Author: Koren H.S.

Infections, immunological stressors and the development of allergy
pp. 16-16(1)
Authors: McWilliam A.S.; Holt P.G.

An introduction to endocrine disruption science
pp. 16-17(2)
Author: Jegou B.

Xenoendocrine disrupters - laboratory studies on male reproductive effects
pp. 17-17(1)
Authors: Gray L.E.; Kelce W.

Xenoendocrine disrupters - environmental impacts
pp. 17-17(1)
Author: Sumpter J.P.

Ah Receptor agonists as endocrine disruptors: antiestrogenic activity and mechanisms
pp. 17-17(1)
Author: Safe S.

Dietary phytoestrogens and their role in hormonally dependent diseases
pp. 17-18(2)
Authors: Makelaa S.; Strauss L.; Santti R.

The role of apoptosis in toxic cell killing in the immune system
pp. 18-18(1)
Author: Orrenius S.

Lead-induced alterations in retinal cGMP PDE gene expression and activity result in cell-specific apoptosis during development
pp. 18-18(1)
Authors: Fox D.A.; Srivastava D.; Poblenz A.T.; He L.

Interactions of excitatory neurotransmitters and xenobiotics in excitotoxicity and oxidative stress
pp. 18-18(1)
Authors: Savolainen K.M.; Naarala J.; Eerikainen S.; Loikkanen J.

Methamphetamine toxicity and its molecular mechanisms of action
pp. 18-19(2)
Authors: Stadlin A.; Cadet J.L.

Mechanisms of quinolone phototoxicity
pp. 19-19(1)
Author: Shimoda K.

The photomutagenicity of fluoroquinolones and other drugs
pp. 19-19(1)
Authors: Gocke E.; Albertini S.; Chetelat A.A.; Kirchner S.; Muster W.

Photochemical genotoxicity and photochemical carcinogenesis - two sides of a coin?
pp. 19-19(1)
Author: Muller L.

The photocarcinogenic potential of drugs in humans
pp. 20-20(1)
Author: Stern R.S.

Advances in morphometry and stereology in toxicologic pathology
pp. 20-20(1)
Author: Collan Y.

Effects of human PTH (1-34) and bisphosphonate on the osteopenic rat model
pp. 20-20(1)
Author: Tanizawa T.

Correlation of mechanistic data and histopathology in the evaluation of selected toxic endpoints of the endocrine system
pp. 20-20(1)
Author: Capen C.C.

New approaches to the quantitation of hypertrophy and hyperplasia in hepatomegaly
pp. 20-21(2)
Authors: Carthew P.; Edwards R.E.; Nolan B.M.

The role of physiological indices in detecting and understanding neurotoxicity
pp. 21-21(1)
Author: Ray D.E.

Biochemical and molecular neurotoxicology: relevance to neurotoxicity testing and risk assessment
pp. 21-21(1)
Author: Costa L.G.

Developmental aspects in neurobehavioural toxicology: contribution to risk assessment for environmental neurotoxicants
pp. 21-21(1)
Authors: Winneke G.; Kramer U.; Walkowia J.; Steingruber H.J.

Risk assessment of domoic acid with the use of quantitative histological techniques
pp. 21-22(2)
Authors: Slikker W.; Scallet A.C.; Gaylor D.W.

Application of AMS in adduct identification and quantification
pp. 22-22(1)
Authors: Turteltaub K.; Dingley K.; Mani C.; Vogel I.

Use of polyclonal antibodies against carcinogen-DNA adducts and analysis
pp. 22-22(1)
Authors: Shirai T.; Takahashi S.; Tada M.; Kadlubar F.

PCR-based approaches to adduct analysis
pp. 22-22(1)
Authors: Pfeifer G.P.; Tang M.-s.; Denissenko M.F.

New developments in the ³²P-postlabelling analysis of DNA adducts
pp. 22-23(2)
Author: Hemminki K.

Knockout animals in toxicology: assessment of toxin bioactivation pathways using mice deficient in xenobiotic metabolizing enzymes
pp. 23-23(1)
Authors: Pineau T.; Costet P.; Puel O.; Leszckowicz A.; Lesca P.; Alvinerie M.; Galtier P.

Current status of transgenic bioassays for carcinogens
pp. 23-23(1)
Author: Tennant R.W.

Validation of transgenic mice harboring the human prototype c-Ha-ras gene as a bioassay model for rapid carcinogenicity testing
pp. 23-23(1)
Authors: Yamamoto S.; Nomura T.

Mode of action considerations in the use of transgenic animals for mutagenicity and carcinogenicity evaluations
pp. 23-24(2)
Authors: Gollapudi B.B.; Stott W.T.; Yano B.L.; Bus J.S.

Molecular failure of apoptosis: inappropriate cell survival and mutagenesis?
pp. 24-24(1)
Authors: Williams G.T.; Critchlow M.R.; Hedge V.L.; O'Hares K.B.

Mechanisms of P53-induced apoptosis
pp. 24-24(1)
Authors: Choisy-Rossi C.; Reisdorf P.; May E.; Yonish-Rouach E.

Molecular and genetic aspects of toxicant-induced apoptosis in the female germ line
pp. 24-25(2)
Author: Tilly J.L.

Molecular and genetic aspects of toxicant-induced apoptosis in the male germ line
pp. 25-25(1)
Authors: Lee J.; Richburg J.H.; Li G.; Boekelheide K.

Experimental and clinical toxicology of anticholinesterase agents
pp. 25-25(1)
Author: Moretto A.

Health effects of exposures in the gulf war
pp. 25-25(1)
Author: Spencer P.S.

Epidemilogic association in US veterans between Gulf War illness and exposure to anticholinesterases
pp. 25-26(2)
Author: Kurt T.

Chronic effects of low level exposure to anticholinesterases
pp. 26-26(1)
Author: Ray D.E.

The pharmaceutical industry's experience concerning animal toxicity studies predicting adverse effects in clinical trials-the ILSI/HESI report
pp. 26-26(1)
Author: Olson H.M.

What the clinical pharmacologist wants to know from animal toxicology studies
pp. 26-26(1)
Author: Jorkasky D.K.

Which animal studies are needed to support initial studies in humans - a regulatory perspective
pp. 27-27(1)
Author: Sjoberg P.

The international harmonization of guidelines - a view point from the industry
pp. 27-27(1)
Authors: Lars E.; Astra A.B.

A Japanese view on a global toxicology testing program before ICH1 and after ICH4
pp. 27-27(1)
Author: Mitsumori K.

New perspectives for alternative approaches to carcinogenicity testing: a regulator viewpoint
pp. 27-28(2)
Author: van der Laan J.W.

Application of new approaches to testing for pharmaceutical carcinogenicity
pp. 28-28(1)
Author: DeGeorge J.

Harmonization of approaches to the assessment of risk from exposure to chemicals: a path forward
pp. 28-28(1)
Authors: Sonich-Mullin C.; Younes M.

Harmonisation of risk assessment: carcinogenicity
pp. 28-28(1)
Author: Fielder R.J.

IPCS harmonization of risk assessment; assessment of non-cancer endpoints
pp. 28-29(2)
Author: Meek M.E.

Annual reports by poison control centres
pp. 29-29(1)
Author: Pronczuk J.

Case data severity grading
pp. 29-29(1)
Author: Persson H.

Multi-centre studies
pp. 29-29(1)
Author: Meredith T.J.

European approach to accreditation of toxicologists
pp. 30-30(1)
Author: Fowler J.S.L.

Accreditation in the USA
pp. 30-30(1)
Author: Dourson M.L.

Current status on certification of toxicologists in Japan
pp. 30-30(1)
Author: Kurokawa Y.

The issue of accreditation in developing countries
pp. 30-31(2)
Author: Arboleda C.

Alternative methods for mechanistic studies in toxicology
pp. 31-31(1)
Authors: Ohno Y.; Miyajima A.; Sunouchi M.

Industry experience with alternative methods
pp. 31-31(1)
Author: Leclaire J.

FDA position on validation and acceptance of alternative methods
pp. 31-31(1)
Author: Wilcox N.L.

Use of biomarkers - new frontiers in toxicology
pp. 31-32(2)
Author: Vainio H.

From exposure to target dose: examples from occupational setting
pp. 32-32(1)
Author: Hemminki K.

Use of biomarkers in the elucidation of causal mechanisms
pp. 32-32(1)
Authors: Wild C.P.; Hardie L.J.

Critical genes as early warning signs: example of exposure to vinyl chloride
pp. 32-33(2)
Author: Marion M.J.

Commercial toxicology prediction systems - the current status and the road ahead
pp. 33-33(1)
Author: Richard A.M.

Integrating computer prediction systems with in vitro methods towards a better understanding of toxicology
pp. 33-33(1)
Author: Barratt M.D.

Computer modeling and computational toxicology in new chemical and pharmaceutical product development
pp. 33-33(1)
Author: Hall A.H.

Toxicity prediction of chemicals based on structure-activity relationships
pp. 33-34(2)
Author: Nakadate M.

The contribution of toxicology to the understanding of biology
pp. 34-34(1)
Author: Orrenius S.

Mechanisms of toxicity and risk assessment
pp. 34-34(1)
Author: Smith L.L.

Neurotoxicity of environmental chemicals and their mechanism of action
pp. 34-34(1)
Authors: Tilson H.; Kodavanti P.R.S.; Mundy W.; Bushnell P.

Bridging basic research with practical problems
pp. 34-34(1)
Author: Schlatter C.

Are toxicokinetic investigations feasable in human poisoning?
pp. 34-35(2)
Author: Jaeger A.

Pharmacokinetic/pharmacodynamic (PK/PD) relationships. How are they useful in human toxicology?
pp. 35-35(1)
Author: Baud F.J.

Toxicokinetic and toxicodynamic aspects of organophosphorus (OP) insecticide poisoning
pp. 35-35(1)
Author: Vale J.A.

Toxicokinetics and toxicodynamics of iron poisoning
pp. 35-35(1)
Author: Tenenbein M.

Advantages of toxicokinetics in new drug development
pp. 35-36(2)
Author: Horii I.

Methods for xenoestrogen testing
pp. 36-36(1)
Authors: Safe S.; Gaido K.

Methods for studying xenoestrogenic effects in birds
pp. 36-36(1)
Authors: Berg C.; Halldin K.; Brunstrom B.; Brandt I.

Tiered screening and testing strategy for xenoestrogens and antiandrogens
pp. 36-36(1)
Author: Gray L.E.

Is a positive control useful in the rat in vivo micronucleus test? A comparative study of different routes of administration of cyclophosphamide
pp. 37-37(1)
Authors: Aujoulat M.; Forichon A.; Descotes J.

Use of single cell gel electrophoresis assay for the detection of tissue-specific DNA damage in mouse gastric mucosa after acute oral administration of N-methyl-N'-nitrosoguanidine and -propiolactone
pp. 37-37(1)
Authors: Brault D.; Renault D.; Thybaud V.

Okadaic acid genotoxicity investigated by the comet assay
pp. 37-37(1)
Authors: Fessard V.; Puech L.

DNA damage evaluated by the alkaline comet assay in lymphocytes of humans anaesthetized with isoflurane
pp. 37-37(1)
Authors: Sardas S.; Karabiyik L.; Aygun N.; Karakaya A.E.

Detection of selective genotoxicants by single cell gel electrophoresis and mutation screening assays
pp. 38-38(1)
Authors: Devery S.; Tomkins P.T.

Assessment of DNA damage in nurses handling anti-neoplastic agents by comet assay
pp. 38-38(1)
Authors: Basaran N.; Undeger U.; Kars A.

Use of alkaline comet assay (single cell gel electrophoresis technique) to detect DNA damages in lymphocytes of operating room personnel occupationaly exposed to anaesthetic gases
pp. 38-38(1)
Authors: Karakaya A.E.; Unal Y.; Aygun N.; Gamli M.; Sardas S.

DNA damage deteced by single cell gel electrophoresis in peripheral mononuclear blood cells of ovarian cancer patients during combining chemotherapy with cyclophosphamide/carboplatin
pp. 38-38(1)
Authors: Zhaung Z.X.; Liang L.Z.

Use of the photo-comet assay for evaluation of photochemical genotoxicity
pp. 39-39(1)
Authors: Brendler-Schwaab S.Y.; Kersten B.; Muller L.

DNA damage induced by methylating and alkylating compounds in vitro. A comparative study
pp. 39-39(1)
Authors: Stetina R.; Vodicka P.

Gene-specific damage and repair produced by BPDE or UV in human cells as assayed by the quantitative polymerase chain reaction
pp. 39-39(1)
Authors: Wang Y.-C.; Chang Y.-Y.

A new in vitro DNA excision repair assay for the detection of okadaic acid - nduced DNA damage in vero cells
pp. 39-40(2)
Authors: Baudrimont I.; Traore A.; Cledes F.; Creppy E.E.

Detection of genomic DNA damage induced by genotoxins in mammalian cells by a chemiluminescence micro-plate DNA repair assay
pp. 40-40(1)
Authors: Salles B.; Li R.-Y.; Bozzato C.

Detection of oxidative DNA damage and effects of antioxidants in cell-free and cellular systems by a chemilunescence microplate DNA repair assay
pp. 40-40(1)
Authors: Li R.-Y.; Bozzato C.; Salles B.

Mutagenic activity of hydralazine and dihydralazine in oxyR proficient and deficient Salmonella Typhimurium strains
pp. 40-40(1)
Author: Chlopkiewicz B.

A human in vitro studies on mutagenicity of chemicals
pp. 40-40(1)
Authors: Suzuki S.; Satoh T.; Hakura A.

Establishment of a salmonella tester strain highly sensitive to mutagenic heterocyclic amines
pp. 40-41(2)
Authors: Suzuki A.; Kushida H.; Iwata H.; Watanabe M.; Nohmi T.; Fujita K.; Kamataki T.

Photogenotoxicity and apoptosis in Chinese hamster V79 cells and human HaCaT cells induced by 8-MOP and lomefloxacin under different UVA/UVB treatment conditions
pp. 41-41(1)
Authors: Zhang J.; Kersten B.; Kasper P.; Brendler-Schwaab S.Y.; Muller L.

In vitro investigations of phototoxicity and photogenotoxicity of phenothiazine derivatives
pp. 41-41(1)
Authors: Baudouin C.; Vaissiere C.; Aries M.; Charveron M.; Gall Y.

Genotoxic effects in human white blood cells following styrene (in vivo) and styrene oxide (in vitro) exposure
pp. 41-41(1)
Authors: Marczynski B.; Peel M.; Rozynek P.; Elliehausen J.; Korn M.; Baur X.

In vitro genotoxicity of atmospheric air particles in several towns of Ukraine
pp. 42-42(1)
Authors: Dugan A.M.; Barilyak I.R.; Slyusarenko A.V.

Genotoxicity of aerosol paticles on atmospheric air of some towns in Ukraine (in ames test)
pp. 42-42(1)
Authors: Dugan A.M.; Slyusarenko A.V.; Nester T.I.

Genotoxicity induced by cooking oil fume in rat pulmanory cells
pp. 42-42(1)
Authors: Pu Y.; Yin L.; Li Y.; Lin P.

Diesel exhaust extract-derived DNA adducts in vitro CT DNA and human MCF-7 cell line
pp. 42-42(1)
Authors: Savela K.; Kuljukka T.; Peltonen K.; Mikkonen S.; Rantanen L.

The biomonitoring of 1-OH pyrene in urine and some genotoxic endpoints in asphalt workers exposed to bitumen fumes
pp. 42-43(2)
Authors: Karahalil B.; Burgaz S.; Erdem O.; Karakaya A.E.

Elaboration of a predictive toxicokinetic model for in vivo micronucleus assay
pp. 43-43(1)
Authors: Kles V.; Hyrrien O.; Sanders P.; Poul J.M.

Induced loss of heterozygosity in somatic cells of drosophila melanogaster is a sensitive indicator of genotoxicity
pp. 43-43(1)
Authors: Frei H.; Graf U.; Wurgler F.E.

Recommendations for spacing of test chemical concentrations in the mouse lymphoma tk mutation assay (MLA)
pp. 43-43(1)
Authors: Kirkland D.J.; Clements J.

Chromosome damage in lymphocytes and in exfoliated buccal and nasal mucosa cells of welders
pp. 43-44(2)
Authors: Burgaz S.; Tecimer B.; Erdem O.; Yilmazer M.; Kemaloglu Y.; Karakaya A.E.

Improved detection of DNA adducts by ³²P-postlabeling with on-line HPLC enrichment and blotting
pp. 44-44(1)
Authors: Hock A.; Schmitz O.; Nguyen P.-T.; Richter E.; Dietzel G.

Genotoxic effects of the food color (carmoisine) on the chromosome of bone marrow cells of rat
pp. 44-44(1)
Authors: Ali M.O.; Al-Ghor A.; Sharaf A.K.; Mekkawy H.; Montaser M.M.

Mutations of K-ras oncogene in lung cancer associated with chemical pollutants
pp. 44-44(1)
Authors: Li X.M.; Lu X.B.

Sister chromatid exchange analysis in humans and animals exposed to coke oven pollutants
pp. 44-44(1)
Authors: Hao W.; Xu H.

Genotoxicity of N-nitroso-piperazine derivatives
pp. 44-45(2)
Authors: Pinter A.; Spiegelhalder G.B.; Torok G.; Surjan A.; Csik M.; Kocsis Z.; Seibel J.; Wacker C.-D.

Clastogenic changes caused by As 5 in cultured cho cells: a comparison with As 3
pp. 45-45(1)
Authors: Kochhar T.S.; Nelson W.; Turner D.

Genotoxic effects of 8-chloro-cyclic adenosine monophosphate in BALB/C mice
pp. 45-45(1)
Authors: Bajic V.; Milutinovic D.; Stanimirovic Z.

Cytotoxicity and DNA-adducts induced by Pt and Pd mercaptopyridine complexes
pp. 45-45(1)
Authors: Carrara M.; Biasio G.; Berti E.; Berti T.; D'Ancona S.; Vedaldi D.

Measurement of N3-(2-hydroxypropyl)deoxyuridine (3-HPdUrd), a propylene oxide (PO) DNA adduct, by liquid chromatography tandem mass spectrometry (LC/MS/MS)
pp. 45-46(2)
Authors: Rios-Blanco M.N.; Koc H.; Faller T.; Solomon J.J.; Filser J.G.; Swenberg J.A.

Inhibition by quercetin of carcinogen activation, via cloned human and rat P-450
pp. 46-46(1)
Authors: Lautraite S.; Doehmer J.; Chipman J.-K.

Effect of sodium butyrate towards benzo(a)pyrene mutagenesis
pp. 46-46(1)
Authors: Cassand P.; Maziere S.; Tavan E.

Genetic damage and effect on cell cycle progression by bile acids in human lymphocytes
pp. 46-46(1)
Authors: Hrelia P.; Fimognari C.; Nusse M.; Maffei F.; Forti G.C.

Subchronic, chronic, pharmacokinetic and genotoxicity studies with polyox⁽R) water soluble resin
pp. 46-47(2)
Authors: Ballantyne B.; Leung H.-W.; Hermansky S.J.; Frantz S.W.

Several biochemical results of Thio-TEPA influence in vivo upon albino rats
pp. 47-47(1)
Authors: Parsadanian H.K.; Marchenko S.N.; Neumerzhitskaya L.V.; Barilyak I.R.

Physiochemical properties of chromatin, a molecular assay for genotoxic effects of environmental pollutants
pp. 47-47(1)
Authors: Badr E.; Seehy M.; Youssef M.K.; El-Shehawy A.

Results of general toxicity and genotoxicity studies of a new insecticide synergist
pp. 47-47(1)
Authors: Sebestyen I.; Beres E.; Pasics-Szakonyi I.; Olah B.

Results of genotoxicity studies of a new acaricide
pp. 47-47(1)
Authors: Beres E.; Pap L.; Hirka G.

Cloning and genomic organization of the human glutathione transferase A4 gene
pp. 48-48(1)
Authors: Desmots F.; Rauch C.; Guillouzo A.; Fabrice M.

Combined effect of high temperrature and nicotine on HSPs genes expression and their regulation
pp. 48-48(1)
Authors: Tang P.T.; Zhaung Z.X.; He H.Z.; Zhang G.G.

Cytogenetic and molecular genotoxic effects of vertemic
pp. 48-48(1)
Authors: El-Khatib H.N.; Hamam F.M.; Salama M.S.

Role of cell proliferation on the fixation of DNA-adducts into gene mutations in liver of 5,9-dimethyl-dibenzocarbazole treated muta^TM mouse
pp. 48-48(1)
Authors: Tombolan F.; Renault D.; Brault D.; Guffroy M.; Perin F.; Thybaud V.

Artificial heterozygote analysis: a novel approach for the efficient identification of point mutations
pp. 49-49(1)
Authors: Staedtler F.; Pospiech A.; Steiner S.; Looser M.

Use of metallothionein-transgenic and knock-out mouse models for the study of cadmium toxicity
pp. 49-49(1)
Authors: Klaassen C.D.; Liu J.

Background data of transgenic mice carrying the human prototype c-Ha-ras gene
pp. 49-49(1)
Authors: Hioki K.; Ohashi H.; Urano K.; Wakana S.; Yamamoto S.; Usui T.; Nomura T.

Transgenic animal models: their role in the acceleration and modification of the drug development process
pp. 49-49(1)
Authors: Spainhour C.B.; Ciofalo V.B.

Studies on tamoxifen - induced mutations in the livers and uteri of big blue^TM transgenic F344 rats
pp. 49-50(2)
Authors: Styles J.A.; Davies R.; Fenwick S.; Walker J.; Martin E.; White I.N.H.; Smith L.L.

Benzodiazepine- and alcohol-induced ataxia in a cerebellar GABA-A receptor subtype-deficient mouse line
pp. 50-50(1)
Authors: Korpi E.R.; Koikkalainen P.; Pyykko K.; Wisden W.

Induction of CYP1A1/2 and oxidative stress by primaquine in human and rat hepatocytes
pp. 50-50(1)
Authors: Fontaine F.; de Sousa G.; Lesca P.; Rahmani R.

Cytoprotective effect of anethole dithiole thione (sulfarlem⁽R)) as a free radical scavenger-evaluation by microplate cytofluorimetry
pp. 50-50(1)
Authors: Christen M.-O.; Osseni R.; Debbasch C.; Maugard J.; Rat P.; Warnet J.-M.

Oxidative stress and adhesive properties of endothelial cells to extracellular matrix
pp. 51-51(1)
Authors: Lamari F.; Braut-Boucher F.; Bernard M.; Pichon J.; Font J.; Aubery M.; Foglietti M.J.

Alteration of the dopamine transporter (DAT) function: an implication of multiple factors all induced by an oxidative stress
pp. 51-51(1)
Authors: Morel P.; Fauconneau B.; Piriou A.; Tallineau C.; Huguet F.

Involvement of cytochrome P450 4A family in the oxidative metabolism of 4-HNE
pp. 51-51(1)
Authors: Gueraud F.; Alary J.; Costet P.; Debrauwer L.; Dolo L.; Pineau T.; Paris A.

Antioxidative stress properties of some garlic components diallylsulfide; diallyldisulfide; allyl mercaptan and allylmethyl sulfide
pp. 51-52(2)
Authors: Fanelli S.L.; Castro G.D.; de Toranzo E.G.D.; Castro J.A.

The antioxidative mechanisms of tea in the prevention of cancer
pp. 52-52(1)
Author: Qi L.

Effects of wine complex polyphenols against liver oxidative DNA damage in rats treated with 2-nitropropane
pp. 52-52(1)
Authors: Casalini C.; Lodovici M.; Paganelli G.; Dolara P.

Antioxidant properties and radical scavenging activities of phenolic compounds extracted from Vitis vinifera cell cultures
pp. 52-52(1)
Authors: Fauconneau B.; Huguet F.; Waffo-Teguo P.; Merillon J.M.; Piriou A.

Evaluation of the production of oxidative stress by toxin T514 of Karwinskia humboldtiana
pp. 52-53(2)
Authors: Garza-Ocanas L.; Acosta D.; Torres-Alanis O.; Pineyro-Lopez A.

Adriamycin-induced free radical-dependent induction of the mitochondrial permeability transition
pp. 53-53(1)
Author: Wallace K.B.

DNA damage and cell death induced by salsolinol through oxidative stress
pp. 53-53(1)
Authors: Kim H.-J.; Jung Y.-J.; Lee J.-M.; Surh Y.-J.

Correlation between glutathione S-transferase activity and lipid peroxide formation in liver of weanling rats under paracetamol treatment
pp. 53-53(1)
Authors: Allameh A.; Nikseresht S.; Ghofrani S.; Farahani M.

Copper sulfate pretreatment inhibits MPP+-induced striatal lipid peroxidation (LPO) in mice
pp. 53-54(2)
Authors: Alcaraz-Zubeldia M.; Rios C.

The effect of antioxidants on the electrical charge density and lipid peroxidation of erythrocytes in methanol intoxication
pp. 54-54(1)
Authors: Dobrzynska I.; Skrzydlewska E.; Figaszewski Z.

Phototoxicity of phthalocyanines
pp. 54-54(1)
Authors: Zavodnik I.; Zavodnik L.; Bryszewska M.

Lipid peroxidation as a consequence of aluminum toxicity in human skin fibroblast cultures: prevention by superoxide dismutase + catalase, vitamin E and vitamin C
pp. 54-54(1)
Authors: Anane R.; Creppy E.E.

The influence of long term administration of arsenic (III and V) on lipid peroxidation, glutathione (GSH) content and the activity of selenoenzymes in the liver of rats
pp. 54-54(1)
Authors: Eybl V.; Caisova D.; Koutensky J.; Brtko J.

Effects of arsenic chronic exposure on central gabaergic systems of mice
pp. 54-55(2)
Authors: De La Cruz-Aguilera D.L.; Rios-Castaneda C.

Lipid peroxidation (LP) in brain regions of developing rats induced by chronic low-level thallium administration
pp. 55-55(1)
Authors: Galvan-Arzate S.; Santamaria A.; Vazquez M.; Martinez M.; Martinez A.; Andres L.; Rios C.

Adaptation of rat liver and kidney antioxidant defenses after d-amphetamine repeated administration
pp. 55-55(1)
Authors: Carvalho F.; Fernandes E.; Remiao F.; Sousa P.; Bastos M.d.L.

Effect of ascorbic acid on mercuric chloride toxicity in adrenal liver and kidney of mice
pp. 55-55(1)
Authors: Rao M.V.; Patil G.R.

Nickel-induced oxidative stress, disruption of mitochondrial integrity and cytotoxicity in human lung fetal fibroblasts (MRC-5 cells)
pp. 56-56(1)
Authors: Zhuang Z.X.; Zhang J.Z.; Huang H.X.; Tang P.T.; Zhang B.Y.

The activity of antioxidative enzymes in erytrocytes of workers occupationally exposed to lead
pp. 56-56(1)
Authors: Bulat P.; Vidakovic A.

Comparative analysis of kinetic peroxidation of blood serum induced by ozone
pp. 56-56(1)
Authors: Abdrashitova N.F.; Kamilov F.K.; Krivochighina L.V.

Oxidative processes in liver microsomes of low-dose -irradiated rats
pp. 56-56(1)
Authors: Zavodnik L.; Zavodnik I.; Bryszewska M.; Buko V.

Toxic effects of radiation-derived lipid peroxidation products on liver microsomal membrane
pp. 57-57(1)
Author: Artsukevich A.N.

Effect of selenium deficiency on oxidative stress-induced 8-isoprostane formation by bovine arterial endothelial cells
pp. 57-57(1)
Authors: Hara S.; Shoji Y.; Sakurai A.; Himeno S.; Imura N.

Metallothionein protects the heart from oxidative injury
pp. 57-57(1)
Author: Kang Y.J.

Modulation of hexachlorobenzene induced liver oxidative stress by -tocopherol
pp. 57-57(1)
Authors: Almeida M.G.; Ropke C.D.; Davino S.C.; Nobre F.A.F.; Santos E.; Barros S.B.M.

Studies on vitamin B1 degradation under the action of tretbutyl hydroperoxide
pp. 58-58(1)
Authors: Melnichenko N.G.; Zverinsky I.V.; Zabrodskaya S.V.

Oxidatives stress in human poisoning cases following malathion and propoxur ingestion
pp. 58-58(1)
Authors: Banerjee B.D.; Seth V.; Bhattacharya A.; Chakraborty A.K.; Pasha S.T.

New methods for oxidative stress assessment (GSH, H₂O₂), directly in living adherent cells Using microplate cold light cytometry
pp. 58-58(1)
Authors: Rat P.; Osseni R.; Debbasch C.; Christen M.O.; Warnet J.-M.

Analysis of mitochondrial ND1 mutations in Parkinson's disease
pp. 58-59(2)
Authors: Kirchner S.C.; Farin F.M.; Van Loo J.; Smith-Weller T.; Franklin G.M.; Swanson P.D.; Dilley J.; Checkoway H.

Telomere length of regenerating proximal tubular epithelial cells in the rat kidney
pp. 59-59(1)
Authors: Sehata S.; Manabe S.; Takaoka M.

The effects of diet, Ad libitum (AL) overfeeding and moderate or marked dietary restriction (DR) on body weight (BW), survival, clinical pathology parameters, and cause of death in control Sprague-Dawley (SD) rats
pp. 59-59(1)
Authors: Hubert M.-F.; Laroque P.; Gillet J.-P.; Keenan K.

Potentiation of metal induced reactive oxygen species formation by -amyloid
pp. 59-59(1)
Authors: Bondy S.C.; Guo-Ross S.X.; Truong A.T.

The influence of age on lethality of intoxicated patients
pp. 60-60(1)
Author: Vieira R.J.

Pharmacokinetics of active metabolites of ethyl loflazepate (Lof) in the aged
pp. 60-60(1)
Authors: Kamijo Y.; Lin Z.B.; Kondo R.; Soma K.

Gonadal and reproductive capacity under conditions of radiation background increase
pp. 60-60(1)
Author: Shepelskaya N.

Immunostimulating and therapeutical activities of enzymes preparation from streptomycete by X-ray radiation
pp. 60-60(1)
Authors: Kylochek T.P.; Sokolova I.E.; Chernogor N.P.; Babenko U.S.

Soil burrowers-phytophagans participation in the soil -radioactivity decrease
pp. 60-61(2)
Authors: Bulakhov V.L.; Pakhomov A.E.

Low dose radiation effect on proteinase-inhibitor system in agricultural plants from Chernobyl zone
pp. 61-61(1)
Author: Filonik I.A.

Biochemical test-systems in estimation of radioactive pollution effect on plants
pp. 61-61(1)
Authors: Filonik I.A.; Dyachenko M.P.

Spermatogenesis disorders in mice from Chernobyl experimental population
pp. 61-61(1)
Authors: Lakiza O.; Stefanovich A.; Kaplina V.; Barilyak I.

Identification of genes involved in neoplastic transformation induced by high let radiation using differential display
pp. 62-62(1)
Authors: Dechang W.; Gang L.; Yingchun H.; Yongliang Z.; Xiaoqiong X.

Foliar malformation of the cerebellum in rats caused by X-radiation
pp. 62-62(1)
Authors: Inouye M.; Darmanto W.; Takagishi Y.; Ogawa M.; Mikoshiba K.; Murata Y.

Reclassification of toxicity for radionuclides
pp. 62-62(1)
Authors: Li W.B.; Ye C.Q.; Li J.; Zheng W.Z.

Early genotoxic effects and features of delayed consequences after low doses radiochemical exposures
pp. 62-62(1)
Authors: Ivanov S.D.; Kovanko E.G.

The preliminary study of relevant genes of miner's lung cancer
pp. 62-63(2)
Authors: Ye C.Q.; Yang M.Y.; Yao S.X.; Zhang J.; Liu L.H.

Modification of the toxic activity Cs-137 under effect 50 Hz magnetic fields
pp. 63-63(1)
Author: Tomashezskaya L.A.

Effects of neurotoxins in rat cortical neuron cultures: role of cellular energy supply and cytoskeleton
pp. 63-63(1)
Authors: Ahr H.J.; Schmuck G.; Freyberger A.

Neurotoxic effect of Na₂S, a soluble salt of hydrogen sulphide, on striatal slices of rat brain
pp. 63-63(1)
Authors: Cordova-Moreno R.; Roth S.; Rios C.

Assessment of pain in fluorosis-induced rats
pp. 63-64(2)
Authors: Coudore F.; Nicolay A.; Gillet J.P.; Reynier J.P.; Delort P.

Suramin is an antagonist of a presynaptic neurotoxin in mouse neuromuscular junctions
pp. 64-64(1)
Authors: Lin-Shiau S.Y.; Lin M.J.

Effect of selenium on central nervous system of male S-D rats: evidences for neurotoxicity of selenium
pp. 64-64(1)
Authors: Rasekh H.R.; Soliman K.F.A.; Davis M.D.

Changes in brain monoamine oxidase B in rat exposed to styrene
pp. 64-64(1)
Authors: Coccini T.; Randine G.; Manzo L.; Costa L.G.

Neurological and biochemical effects of occupational exposure to benzene
pp. 64-65(2)
Author: Muzyka V.

Ethanol inhibits carbachol-induced calcium responses in glial cells in a concentration- and time-dependent manner
pp. 65-65(1)
Authors: Catlin M.C.; Costa L.G.

Gabaergic-benzodiazepine system is involved in the crotoxin-induced behavioral alterations
pp. 65-65(1)
Authors: Vassilieff V.S.; Moreira E.G.; Nascimento N.; Rogero J.R.

The influence of L-carnitine on effect and biodistribution of cognition activator 7-methoxytacrine in preclinical testing
pp. 65-65(1)
Authors: Svoboda Z.; Herink J.; Bajgar J.; Kvetina J.

Cyanide-induced neurodegeneration involves multiple pathways in select brain areas
pp. 65-66(2)
Authors: Isom G.E.; Mills E.M.; Borowitz J.L.; Gunasekar P.G.

Dopaminergic involvement in the pharmacological actions of buspirone
pp. 66-66(1)
Authors: Badawi M.M.; El-Mossalamy N.T.; Shehata A.M.

Effect of tiazofurin on proliferation and differentiation of C6 rat glioma cells
pp. 66-66(1)
Authors: Piperski V.; Vracar M.; Drabek K.; Papovic M.; Jovanovic S.; Jokanovic M.; Rakic L.

Coordinated regulation of gene expression from the acetylcholinesterase locus
pp. 66-66(1)
Authors: Shapira M.; Korner M.; Bosgraaf L.; Hinzmann B.; Rosenthal A.; Soreq H.

Corpus striatum long-lasting effects in adult mice prenatally treated with diazepam
pp. 66-67(2)
Authors: Marquez-Orozco A.; Marquez-Orozco M.C.; Gazca-Ramirez M.V.; de la Fuente-Juarez G.

Dapsone protects against kainic acid-induced damage on central gabaergic and serotonergic systems
pp. 67-67(1)
Authors: Osorio-Rico L.; Rios C.

Daunorubicin stimulates dopamine release from rat hypothalamic neuronal endings in vitro
pp. 67-67(1)
Authors: Brunetti L.; Michelotto B.; Orlando G.; Vacca M.

Regional selectivity to ochratoxin A, distribution and cytotoxicity in rat brain
pp. 67-67(1)
Authors: Belmadani A.; Betbeder A.M.; Tramu G.; Steyn P.S.; Creppy E.E.

Aluminium neurotoxicity in young adult mice following transcutaneous exposure
pp. 67-68(2)
Authors: Anane R.; Carratu M.-R.; Labate M.; De Santis S.; Creppy E.E.

Neurotoxicant-induced alterations in the somatosensory cortical evoked potential of the rat. A search for functional biomarkers
pp. 68-68(1)
Authors: Papp A.; Nagymajtenyi L.; Desi I.

Protective effect of non-competitive NMDA antagonist MK-801 in methyl mercury induced neuronal injury
pp. 68-68(1)
Author: Miyamoto K.-i.

Protective effects of zinc on 2,5-hexanedione neurotoxicity studied with analytical and behavioral methods in rats
pp. 68-68(1)
Authors: Mateus M.L.; dos Santos A.P.M.; Batoreu M.C.C.

Effects of snake venom naja naja Oxiana (N.n.o) on neuromuscular transmission invitro
pp. 68-68(1)
Authors: Vatanpour H.; Asadi P.A.; Akbari A.; Zolphagarian H.

Investigation of combined lead and ethanol exposure of rats during pregnancy, lactation, and postweaning. A behavioural and neurotoxicological study
pp. 69-69(1)
Authors: Nagymajtenyi L.; Schulz H.; Papp A.; Desi I.

Behavioural and neurophysiological changes caused by arsenic in different developmental stages
pp. 69-69(1)
Authors: Desi I.; Nagymajtenyi L.; Schulz H.; Papp A.

Hypocalcemic effect and behavioral toxicity of radio- and chemoprotector amifostine
pp. 69-69(1)
Authors: Dobric S.; Bokonjic D.

A comparison of the long-term behavioral effect after 28 days inhalation exposure to dimethylbenzene (M-xylene) and isomers of trimethylmenzne (pseudocumene, hemimellitene, mesitylene) in rat
pp. 69-69(1)
Authors: Wiadema D.; Gralewicz S.; Tomas T.

On the characteristic features of behavioural teratogenicity after prenatal aluminum exposure in rat pups
pp. 70-70(1)
Authors: Lehotzky K.; Gonda Z.; Tatrai E.

Altered sexual behavior in the Japanese quail as an endpoint for endocrine disruption
pp. 70-70(1)
Authors: Halldin K.; Berg C.; Brandt I.; Brunstrom B.

Low doses of 9-tetrahydrocannabinol induce hyperaggressiveness in magnesium-deficient rats
pp. 70-70(1)
Authors: Pages N.; Dhalluin S.; Herrenknecht C.; Dupont C.; Bac P.

Neonatal developmental effects of nicotine in mice: changes in brain nicotinic receptors and behavioural response to nicotine
pp. 70-70(1)
Authors: Ankarberg E.; Fredriksson A.; Eriksson P.

Methanol intoxication about 81 cases of mass intoxication occurred in Safi in October 97
pp. 71-71(1)
Authors: Moubarik A.; Benkirane R.; Soulaymani R.

Percutaneous absorption of metallic cations: particularities of uranium
pp. 71-71(1)
Authors: Gerasimo P.; Cazoulat A.; Tymen H.; Blomet J.

Adverse drug reaction (ADR) monitoring of aminoglycosides (AG) in Rajavithi hospital
pp. 71-71(1)
Authors: Sriwatanakul K.M.; Patimaarak S.; Yoovathaworn K.; Sriwatanakul K.

Voluntary drug intoxication in emergency wards (EW) in France
pp. 71-72(2)
Author: Staikowsky F.

Structure of mortality of patients with acute poisonings in large industrial center (1992-1997)
pp. 72-72(1)
Authors: Sarmanaev S.K.; Almuchametov M.A.; Khafisov N.K.; Camalova E.G.; Tchvaluk N.V.; Tuktarova R.R.; Teregulova Z.S.

Telemedicine in management of chemical accidents. Results of a multicenter study in Italy
pp. 72-72(1)
Authors: Butera R.; Locatelli C.; Gandini C.; Zanuti M.; Varango C.; Petrolini V.; Candura S.M.; Minuco G.; Giordano A.; Manzo L.

Annual report of Tehran drug & poison information center in 1997
pp. 72-72(1)
Authors: Abdollahi M.; Baradaran M.; Etebari M.; Ghanea T.; Karimi G.; Kebriaeezadeh A.; Nikfar S.; Rahgozar M.; Saberi M.; Sharifzadeh M.

Chemical emergency medical guidelines - example of responsible care in an international chemical company
pp. 72-73(2)
Authors: Pallapies D.; Klees J.; Conner P.R.; Zober A.

Children poisoning ingestion changes over time. Does the pediatrician's approach change too?
pp. 73-73(1)
Authors: Marchi A.G.; Renier S.; Barbone F.

Selfpoisonings in children up to 14 years of age in the city Lodz, Poland
pp. 73-73(1)
Author: Kotwica M.

Acute realgar herbal poisoning - two cases report
pp. 73-73(1)
Authors: Deng J.F.; Wu M.L.; Tsai W.J.; Ger J.; Yang C.C.

Podophyllotoxin kinetics in plasma by liquid chromatography (HPLC)
pp. 73-74(2)
Authors: Gamelin L.; Harry P.; Gamelin E.; Boisdron-Celle M.; Costerousse F.

Infrequent morphine adverse effects: case report of a pediatric patient
pp. 74-74(1)
Authors: Abbinante A.F.y.P.; Pasqualatto D.

Case report of a massive intoxication by Yohimbine
pp. 74-74(1)
Authors: Mignot G.; Le Normand I.; Caubet A.; Breurec J.Y.; Feuillu A.; Curtes J.P.; Krebs J.

Successful treatment of cibenzoline succinate poisoning using direct hemoperfusion (DHP)
pp. 74-74(1)
Authors: Kondo R.; Aoyama N.; Sasaki T.; Yoshida M.; Suzuki K.; Kamijo Y.; Asari Y.; Soma K.; Izumi T.; Ohwada T.

The possible way of decrease of conditioning regimen toxicity in bone marrow transplantation pediatric patients
pp. 74-75(2)
Authors: Pachanov E.; Skorobogatova E.; Kryzhanovsky O.; Maschan A.

Analysis of toxin of Buthotus S. scorpion in Iran
pp. 75-75(1)
Authors: Azizi E.; Montazeri M.T.; Farzami B.; Akbari A.; Zarea A.; Kheirabadi M.; Taghavi-Manesh A.

Some cytokines, BAL- and antioxidant state parameters involved in pathomechanisms after exposure to short and long industrial fibers
pp. 75-75(1)
Authors: Hurbankova M.; Kaiglova A.; Kovacikova Z.

The influence of coenzyme Q on some biochemical parameters in workers at occupational exposure
pp. 75-75(1)
Authors: Marchewka Z.; Dlugosz A.; Sawicka E.; Lembas-Bogaczyk J.

The effect of ethanol and N-acetylcysteine on the proteolytic-antiproteolytic balance in methanol intoxication
pp. 75-76(2)
Authors: Skrzydlewska E.; Farbiszewski R.

Concentrations of two disulfiram metabolites: diethyldithocarbamic acid and copper bis (diethyldithocarbamate) in plasma samples of alcoholics after oral single dose of disulfiram
pp. 76-76(1)
Authors: Djukic M.; Miljkovic B.; Nedeljkovic M.; Pokrajac M.; Antonijevic B.

Protection exerted by antiproteasic substances against toxic effects induced by chemotherapic agents
pp. 76-76(1)
Authors: Cerrati A.; Bonfioli C.; Dacco R.; Keble M.; Motta F.; Vota M.

Unusual diagnosis: non occupationnal adult lead poisoning
pp. 76-76(1)
Authors: Breurec J.Y.; Baert A.; Anger J.P.; Curtes J.P.

A hospital experience of 32 acute poisonings deliberately inflicted upon other people. Products and purposes
pp. 76-76(1)
Authors: Bismuth C.; Pierlot P.; Borron S.W.; Baud F.J.

An evaluation of the acute toxicity of antidepressants using mortality data, literature LD₅₀ values, and the TOPKAT^TM programme
pp. 77-77(1)
Authors: Darcy P.; Kelly J.P.; Leonard B.E.; Chambers P.L.

Toxic hepatitis among workers eliminating breakdown in a dangerous refuse burning plant
pp. 77-77(1)
Authors: Szabo K.; Kakosy T.; Kornyei Z.; Laszlo A.; Losonczy F.; Ludvan M.

Multiple-site carcinogenesis in a worker exposed to gasoline and diesel fuel
pp. 77-77(1)
Authors: Brandi G.; Fabri G.; Castagnoli A.

Paramagnetic centers (PMC) of blood in patients with opium intoxication under the influence of hemosorption
pp. 77-78(2)
Authors: Zobnin J.V.; Sajfutdinov R.G.; Provado I.P.

Oral leukoplakia in glass works employees in bialystok, Poland
pp. 78-78(1)
Authors: Dabrowska E.; Waszkiel D.; Stokowska W.

Ethanol poisoning in children
pp. 78-78(1)
Authors: Vachos P.; Valti E.; Fountas K.; Tzola E.; Vlahos S.P.

Quality of life (QOL) in patients with sarin intoxication event in Japan
pp. 78-78(1)
Authors: Oyagi T.; Fukushima J.; Shiomitsu H.; Komatsu S.; Nakamura Y.; Utsunomiya K.; Kurinami H.; Kimura H.; Hayashi R.; Fujita H.; Nomura F.; Adachi K.; Mandai T.

Persistent neurological sequelae following chronic exposure to carbon monoxide
pp. 78-79(2)
Authors: Bayer M.J.; Orlando J.; McCormick M.A.; Weiner A.; Deckel A.W.

Colchicine poisoning from accidental ingestion of colchicum autumnale leaves
pp. 79-79(1)
Authors: Locatelli C.; Petrolini V.; Varango C.; Butera R.; Gandini C.; Manzo L.

An study of poisoning in pediatric patients registered by ''CIATO'' during a five years period (1993-1997)
pp. 79-79(1)
Authors: Abbinante A.F.; Pasqualatto D.; Amaro M.I.; Venegas G.

A review of acute poisoned cases received by CIATO during 1993-1997
pp. 79-79(1)
Authors: Pasqualatto D.; Abbinante A.F.; Amaro M.I.; Venegas G.

Seizures and beta-blockers poisoning
pp. 79-79(1)
Authors: Vucinic S.; Vucinic Z.; Segrt Z.; Joksovic D.; Randjelovic S.

Chemical submission: a new concept in forensic medicine
pp. 79-80(2)
Authors: Bismuth C.; Dally S.; Lagier G.

Silicosis related changes in serum copper
pp. 80-80(1)
Authors: Cojocaru M.; Dinu E.; Mitrea M.

NMR spectroscopy as a tool for diagnosis of acute poisonings
pp. 80-80(1)
Authors: Imbenotte M.; Azaroual N.; Maschke S.; Mathieu D.; Leclerc F.; Vermeersch G.; Lhermitte M.

Emergency preparedness facing accidental releases of toxic gases
pp. 80-80(1)
Authors: Baert A.; Breurec J.Y.; James B.; Curtes J.P.

Prospective study on the intoxications in carbon monoxide in Fes City-Winter 97/98
pp. 80-81(2)
Authors: Moubarik A.; Mikou M.M.; Soulaymani R.

Toxicokinetics of organophosphates: clinical implications
pp. 81-81(1)
Authors: Zoppellari R.; Zatelli R.

HPLC-MS determination of veratridine and cevadine in two fatal cases of veratrum album poisoning
pp. 81-81(1)
Authors: Gaillard Y.; Pepin G.

Factors determining quality of clinical information recorded by physicians on toxicology consulting forms
pp. 81-81(1)
Author: Walubo A.

Effect of low doses of flumazenil (FLZ) on upper airway resistance and work of breathing (WOB) during pure or predominant benzodiazepine (BZD) intoxications
pp. 81-82(2)
Authors: Gueye P.N.; Lofaso F.; Mellerio F.; Harf A.; Vicaut E.; Baud F.J.

Atropine and bispyridinium oxime HI-6 in treatment of physostigmine intoxication in rats
pp. 82-82(1)
Authors: Stojiljkovic M.P.; Maksimovic M.; Jokanovic M.; Kilibarda V.; Pavlovic N.; Boskovic B.

Is obidoxime effective in oxydemeton methyl poisoning?
pp. 82-82(1)
Authors: Szinicz L.; Worek F.; Thiermann H.; Eyer P.

Pharmacokinetics of the oxime HI-6 in organophosphorus insecticide poisoned patients with the impaired renal function
pp. 82-82(1)
Authors: Jovanovic D.; Joksovic D.; Randjelovic S.

Atropine aerosol nasal spray (AAS) application in organophosphate poisoinings (OPI)
pp. 83-83(1)
Authors: Ozyurt G.; Bilgin H.; Gedik M.K.

Comparative efficacy of i.v. pralidoxime vs. NaHCO₃ in rats lethally poisoned with O-P insecticide
pp. 83-83(1)
Authors: Wong A.; Pinheiro M.S.B.; Andrusaitis C.; Matida E.Y.; Tannuri U.; Guedes M.; Rocha L.C.S.

Accidental and occupational mercury exposure: effect of sodium 2,3-dimercaptopropane-1-sulfonate (DMPS) therapy
pp. 83-83(1)
Authors: Torres-Alanis O.; Garza-Ocanas L.; Pineyro-Lopez A.

Studies of oral 2, 3-dimercaptosuccinic acid (DMSA) in the treatment of chronical lead poisoning
pp. 83-83(1)
Author: Weimin N.

Comparison of efficacies of antidotes to the lethal effects of hydrogen cyanide (HCN) in mice
pp. 84-84(1)
Authors: Hume A.S.; Mozingo J.; Chaney L.A.

Disulfiram (antabuse)-ethanol reaction treated by 4-methylpyrazole (4-MP). Two case reports
pp. 84-84(1)
Authors: Harry P.; Asfar P.; Brenet O.; Merheb M.; Derogis V.; Alquier P.

Chemical immunity and catalytic antibodies
pp. 84-84(1)
Author: Rong K.T.

Pamidronate disodium antagonizes vitamin D3-induced toxicosis
pp. 84-85(2)
Authors: Rumbeiha W.K.; Kruger J.; Fitzgerald S.; Nachreiner R.; Kaneene J.; Vrable R.; Richter M.

Sulfur donors as cyanide antidotes
pp. 85-85(1)
Authors: Baskin S.I.; Porter D.W.; Rockwood G.A.; Romano J.A.; Kaiser R.C.; Cook C.M.; Ternay A.L.

Antidotal effect of dihydroxyacetone against cyanide poisoning
pp. 85-85(1)
Authors: Niknahad H.; Ghelichkhani E.

Effect of pralidoxime on the respiratory disorders associated with acute organosphosphate poisoning
pp. 85-85(1)
Authors: Gueye P.N.; Rivieros O.; Lofaso F.; Mellerio F.; Harf A.; Vicaut E.; Baud F.J.

Strategy for assessment of cutaneous and ocular irritation of intermediate products of synthesis
pp. 85-86(2)
Authors: Robles C.; Unkovic J.; Lacheretz F.

Experience with interpretations of 'margins of safety' in human health risk assessment of existing chemicals
pp. 86-86(1)
Authors: Munn S.J.; Gregg C.N.; Schoening G.; Luotamo M.; Hansen B.G.

Evaluation of product risk characterization within the strategic planning process
pp. 86-86(1)
Authors: Smith L.W.; Hamlen S.S.

Programme for the prevention of health hazards caused by industrial substances - results of the toxicological evaluation of chemicals
pp. 86-86(1)
Authors: Beth-Huebner M.; Frohberg H.; Martens G.; Heumann C.; Bartels K.; Radek E.

Toxicological testing strategy for the assessment of chemicals
pp. 87-87(1)
Authors: Gerner I.; Roll R.; Schlede E.; Schulte A.; Wettig K.

Toxicity summaries and data on the internet: a baseline assessment on the transition from paper to electronic access
pp. 87-87(1)
Author: DeWoskin R.S.

Quantitative structure-activity relationship (QSAR) for peroxisome proliferation induced by branched carboxylic acids issued from diester plasticizers metabolism in rats
pp. 87-87(1)
Authors: Lhuguenot J.C.; Macherey A.C.; Paitry M.

Threshold of aneugenic chemicals
pp. 87-87(1)
Authors: Elhkim M.O.; Kles V.; Poul J.M.

Cytogenetic study of the Ag-NOR activity in micronuclei following the exposure to antineoplastic drugs
pp. 88-88(1)
Authors: Kopjar N.; Garaj-Vrhovac V.

Determination of micronuclei induced by antineoplastic drugs using DAPI and giemsa staining techniques
pp. 88-88(1)
Authors: Garaj-Vrhovac V.; Kopjar N.

Micronucleus frequency in nurses occupationally exposed to cytostatic drugs
pp. 88-88(1)
Authors: Kasuba V.; Rozgaj R.; Garaj-Vrhovac V.

Genotoxic effects in peripheral lymphocytes of personnel handling antineoplastic agents
pp. 88-88(1)
Authors: Rozgaj R.; Kasuba V.; Garaj-Vrhovac V.

Cytogenetic consequencies of combined exposure to physical agents and fluorescent dye
pp. 88-88(1)
Authors: Fucic A.; Jazbec A.; Markucic D.

Guideline for assessing health risk from vinyl chloride
pp. 88-89(2)
Author: Czerczak S.

Safety assessment of microbial enzymes: are toxicity studies needed to prove safety?
pp. 89-89(1)
Authors: Hempenius R.A.; Coenen T.M.M.; Aalten H.A.

Chemical safety discettes for the industrial district
pp. 89-89(1)
Authors: Ozyurt G.; Tokyay N.; Kucer N.

P53 codon 72 polymorphism in a Taiwanese lung cancer population: correlation with lung cancer susceptibility and prognosis
pp. 89-89(1)
Authors: Wang Y.-C.; Chen S.-K.; Lee H.-S.; Chen C.-Y.

Tumor profile and potency of chemical carcinogens
pp. 90-90(1)
Authors: Benigni R.; Pino A.; Giuliani A.

Alpha 2u globulin accumulation in male rat kidneys following high doses of DINP: implications for assessment of human cancer risk
pp. 90-90(1)
Authors: Caldwell D.J.; Keller L.H.; Eldridge S.R.; Lington A.W.; McKee R.H.

Elevated bladder cancer risk and occupational exposure to azo dyes
pp. 90-90(1)
Authors: Golka K.; Gieseler F.; Heitmann P.; Reich S.E.; Blaszkewicz M.; Thier R.; Urfer W.; Bolt H.M.

Classification of perchloroethylene (PERC) as a probable human carcinogen: is it supported by the data?
pp. 90-90(1)
Authors: Beyer L.A.; Maier W.E.; Beck B.D.

Some aspects of health risk assessment of manufactured gas plant
pp. 91-91(1)
Authors: Tucek M.; Krysl S.; Maxa K.; Mohyluk I.; Seberova E.; Singh R.; Tenglerova J.; Topolcan O.; Weyand E.H.

Health risk assessment of mercury exposure in dental surgery in the Czech Republic
pp. 91-91(1)
Authors: Tucek M.; Krysl S.

A human health risk assessment of exposure to the cyanobacterial toxin, cylindrospermopsin in drinking water
pp. 91-91(1)
Authors: Moore M.R.; Shaw G.R.; Seawright A.A.; Neville G.R.

Judging carcinogenic and anticarcinogenic potential of chemicals: modeling corrections for weight depression, random effects and correlated changes in tumor rate
pp. 91-92(2)
Authors: Linkoy I.; Shagiahmetov A.; Wilson R.; Gray G.M.

Enhanced systemic tissue distribution after topical versus intravenous TCB (3,3', 4,4'-tetrachlorobiphenyl) administered at equivalent doses: a clear example of route dependency in risk assessment
pp. 92-92(1)
Authors: Qiao G.L.; Riviere J.E.

Assessment of carcinogenic hazard of pesticides
pp. 92-92(1)
Authors: Turusov V.S.; Potapov A.I.; Rakitsky V.N.

Methodology of pesticide risk assessment for humans
pp. 92-92(1)
Authors: Potapov A.I.; Rakitsky V.N.; Tereshkova L.P.

Genotoxicity and non-genotoxicity of chemical carcinogens
pp. 92-92(1)
Authors: Rakitsky V.N.; Potapov A.I.; Revasova Y.A.; Turusov V.S.

Induction of hepatic P450 by pentobarbital in semi-aquatic frog (Rana Pipiens)
pp. 92-93(2)
Authors: Qadri S.Y.; Khan M.A.Q.

Gender differences in pharmacokinetics of sex steroids in animals and man
pp. 93-93(1)
Authors: Zimmermann H.; Kaufmann G.; Graser T.; Oettel M.

Mechanistic study with tetrafluoroethylene (TFE) and tetrafluoroethylcysteine (TFE-CYS) in rats and mice
pp. 93-93(1)
Authors: Keller D.A.; Kelly D.P.; Ross P.E.; Elliott G.S.; Kennedy G.L.; Farrar D.G.; Jung R.; Malinverno G.

Metabolism of the aza-PAH dibenz[A,H]acridine (DBAC) by recombinant human cytochrome P450 isozymes
pp. 93-93(1)
Authors: Yuan Z.-X.; Kumar S.; Sikka H.C.

Norcocaine N-hydroxylation in human and mouse liver microsomes
pp. 93-93(1)
Authors: Konttila J.; Auriola S.; Pellinen P.; Pasanen M.; Juvonen R.O.

The role of vitamins in phase I of xenobiotic biotransformation
pp. 94-94(1)
Authors: Lukienko P.I.; Zverinsky I.V.

Combined deficiency of GSTT1 and GSTM1 alleles in the normal population in Shanghai
pp. 94-94(1)
Authors: Shen J.H.; Lin G.F.; Tan J.W.; Yuan W.X.; Thier R.; Bolt H.M.

Enantioselective bioactivation of benzylic compounds
pp. 94-94(1)
Authors: Landsiedel R.; Pabel U.; Kuhlow A.; Engst W.; Glatt H.R.

The xenobiotic metabolizing and antioxidant enzymes in human breast tumor
pp. 94-94(1)
Authors: Iscan M.; Coban T.; Bulbul D.; Eke B.C.; Aygormez S.; Berberoglu U.

Immobilized microsomes used in DNA adduct study
pp. 94-95(2)
Authors: Jing L.; Tao C.; Guangyun X.; Xiwen H.

Species differences in the effects of model liver enzyme inducers on hepatic UGT-T4 activity and thyroid function
pp. 95-95(1)
Authors: Abadie C.; Lasserre D.; Morel C.; Debruyne E.; Nicod L.; Carmichael N.; Richert L.

Endotoxin suppresses the oltipraz-mediated induction of major hepatic glutathione transferases and cytochromes P-450 in the rat
pp. 95-95(1)
Authors: Maheo K.; Morel F.; Antras-Ferry J.; Langouet S.; Desmots F.; Guillouzo A.

Inhibition of glutathione reductase by isoproterenol oxidation products
pp. 95-95(1)
Authors: Remiao F.; Ferreira H.; Ramos G.; Carvalho F.; Bastos M.L.

Spontaneous circadian rhythm of glutathione and mitochondrial activity measured in living human cells. Interest in chronotoxicology with melatonin
pp. 95-96(2)
Authors: Osseni R.A.; Rat P.; Bogdan A.; Adolphe M.; Warnet J.-M.; Touitou Y.

Protective effects of glutathione on teratogenicity of cadmium hydrochloride in mice
pp. 96-96(1)
Authors: Naya M.; Ishii A.; Yasuda M.

Effect of vicine and divicine on glutathione haemolysis and mortalities in different sex and age in albino rats
pp. 96-96(1)
Authors: Arbid M.S.; Marquardt R.R.; Nada S.A.

Glutathione-s-transferases induction by PCBs in rainbow trout freshly isolated hepatocytes
pp. 96-97(2)
Authors: Perez-Lopez M.; Novoa M.C.; Melgar M.J.

Individual susceptibility to the in vitro haematotoxic effect of PCB126
pp. 97-97(1)
Authors: van den Heuvel R.; Leppens H.; Nuijten J.M.; Schoeters G.

Impacts of cutaneous cytochrome P₄₅₀ induction by benzo[a]pyrene on pentachlorophenol dermal absorption and disposition in three porcine models
pp. 97-97(1)
Authors: Qiao G.L.; Riviere J.E.

Expression of the cytochrome P-450 2B1/2 in rat lung and its modulation by toluene diisocyanate
pp. 97-97(1)
Authors: Pons F.; Corcos L.; Haag M.; Bonnet P.; Mesny L.; Guillouzo A.; Binet S.; Lugnier A.; Frossard N.

The human CYP1A1 negative regulatory element is able to modulate AH receptor mediated transcriptional activity
pp. 97-98(2)
Authors: Hines R.N.; Smolinski S.M.; Piechocki M.P.

CYP2E1 mutation associated with increased chlorzoxazone (CZ) metabolic ability
pp. 98-98(1)
Authors: McCarver D.G.; Hines R.N.; Byun R.; Hichme M.

Design of CYP 2C18 and 2C19 substrates based on hydroxylation of 2-aroyl-thiophenes
pp. 98-98(1)
Authors: Minoletti C.; Mancy A.; Ha-Duong T.; Dijols S.; Dansette P.M.; Mansuy D.

Screening the activity of cytochrome P450 isozymes in toxicological studies
pp. 98-98(1)
Authors: Girre C.; Rizzo-Padoin N.; Moser-Seroux C.; Hispard E.; Dally S.; Leverge R.

Differences in regulation of CYP1A1 expression in the isolated perfused rat liver
pp. 98-99(2)
Authors: Kim J.E.; Kim Y.U.; Ahn M.R.; Sheen Y.Y.

Effects of lindane and ovariectomy on some hepatic cytochrome P-450 (CYP) isoforms in rat
pp. 99-99(1)
Authors: Oropeza L.F.; Sierra-Santoyo A.; Alborus A.; Cebrian M.E.

Acute effects of DDT on cytochrome P-450 (CYP)-Dependent hydroxylation of esteroidal sex hormones in rat
pp. 99-99(1)
Authors: Sierra-Santoyo A.; Alborus A.; Cebrian M.E.

Cytochrome P450 (CYP) isoenzymes in cultured precision-cut human liver slices: effects of oxygen tension
pp. 99-99(1)
Authors: Lerche-Langrand C.; Moronvalle-Halley V.; Chevalier D.; Hoet D.; Leroy D.; Beaune P.; Calmus Y.; Toutain H.J.

The effects of T-2 Toxin exposure on liver drug metabolizing enzymes in rabbit
pp. 100-100(1)
Authors: Guerre P.; Eeckhoutte C.; Burgat V.; Galtier P.

Changes in fatty acid, P450 4A and 2E1 isozyme content in rat liver microsomes by indomethacin
pp. 100-100(1)
Authors: Fracasso M.E.; Piubelli A.; Corrocher R.; Guarini P.; Perbellini G.; Franceschetti P.

Expression of CYP 3A isoform induced by dexamethasone in rat hepatocarcinoma cell line transfected with an episomal vector expressing the antisense IGF-I cDNA
pp. 100-100(1)
Authors: Proust V.; Ellouk-Achard S.; Martin C.; Lafarge-Frayssinet C.; Claude J.R.

In vivo inhibition of hepatic and renal cytochrome P-450 3A isoform by cyclosporins A and G
pp. 100-101(2)
Authors: Ellouk-Achard S.; Martin C.; Dutertre-Catella H.; Thevenin M.; Warnet J.-M.; Claude J.R.

Induction of hepatic phase I and phase II metabolizing enzymes in the female fischer 344 rat by cyclicsiloxanes
pp. 101-101(1)
Authors: McKim J.M.; Wilga P.C.; Kolesar G.B.; Dochterman L.W.; Madan A.; Parkinson A.; Meeks R.G.

Prevention of acetaminophen (APAP) covalent binding and toxicity in CYP-1A2 and CYP-2E1, double-knockout mice
pp. 101-101(1)
Authors: Cohen S.D.; Bruno M.K.; Zaher H.; Buters J.T.; Ward J.M.; Lucas A.M.; Stern S.T.; Gonzalez F.J.

Effects of environmental factors on extrahepatic Cyp2e1 gene expression in mice
pp. 101-101(1)
Authors: Sampol E.; Villard P.H.; Puyoou F.; Seree E.M.; Point-Scoma H.; Lacarelle B.; Durand A.

In vitro metabolism of toborinone by human liver cytochrome P450 isoforms
pp. 101-102(2)
Authors: Abbas R.; Flockhart D.A.; Thacker D.; Bramer S.L.; Cowart D.; Browder N.J.

Effect of glyphosate on microsomal cytochrome P450 gene expression in rat
pp. 102-102(1)
Authors: Wu H.-Q.; Xiao G.-H.; Lei X.-D.; Prough R.A.

CYP1A1 mRNA levels in white blood cells in relation to exposure of PCDDs/PCDFs
pp. 102-102(1)
Authors: Mikalsen A.; Hjertholm H.; Becher G.; Alexander J.

Indolo(3,2-b)carbazole (ICZ) is a weaker AH receptor agonist in vivo than in vitro
pp. 102-102(1)
Authors: Pohjanvirta R.; Juvonen R.; Tuomisto J.T.; Unkila M.; Viluksela M.; Bergman J.; Poellinger L.; Tuomisto J.

Different inactivation of NADPH- and NADH-Dependent chains of rat liver endoplasmic reticulum in tetrachloromethane
pp. 102-102(1)
Authors: Zverinsky I.V.; Melnichenko N.G.

Metabolism of butylbenzyl phthalate in the female wistar rats
pp. 103-103(1)
Authors: Lhuguenot J.C.; Nativelle C.; Picard K.; Chagnon M.C.

Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in lung tissue slices from rodents and man
pp. 103-103(1)
Authors: Richter E.; Engl J.; Tricker A.R.

Pharmacokinetic profiles of methadone enantiomers and its major metabolite in serum, saliva and urine of treated patients
pp. 103-103(1)
Authors: Chikhi-Chorfi N.; Pham-Huy C.; Sandouk P.; Sadeg N.; Pecquart C.; Massicot F.; Galons H.; Scherrmann J.M.; Warnet J.M.; Claude J.R.

¹³C-labeled methyl t-butyl ether: toxicokinetics and characterization of urinary metabolites in man
pp. 103-104(2)
Authors: Nihlen A.; Sumner S.; Lof A.; Johanson G.

Dietary cystine and methionine modulate cyanide metabolism in rat
pp. 104-104(1)
Authors: Sabri M.I.; Tor-Agbidye J.; Palmer V.S.; Lasarev M.R.; Spencer P.S.

Comparative cyanogenic potential of succinonitrile and malononitrile
pp. 104-104(1)
Author: Ballantyne B.

The influence of alcohol on allylnitrile (ALN) metabolism in male Sprague-Dawley rats
pp. 104-104(1)
Authors: Farooqui M.Y.H.; Kieffer K.; Adame N.; Rodriguez C.; Benavides M.

Microdetermination of individual isothiocyantes (ITC), vinyloxazolidinethione (VOT) and nitriles (RCN) in rapeseed cake and dregs
pp. 104-105(2)
Authors: Huaqiong H.; Weige L.; Faming X.

Study of the toxic interaction between monensin and tiamulin in rats
pp. 105-105(1)
Authors: Szucs G.; Danyi D.; Laczay P.

The subcellular distribution of defluorination activity in three mammalian species
pp. 105-105(1)
Authors: Tu L.; Rix C.; Wright P.F.A.; Ahokas J.T.

Activation of microsomal glutathione S-transferase as a tool in environmental and molecular toxicology
pp. 105-106(2)
Authors: de Rooij B.M.; Ruijter E.; Commandeur J.N.M.; Vermeulen N.P.E.

The rodent non-genotoxic hepatocarcinogen nafenopin suppresses apoptosis preferentially in non-cycling hepatocytes, but elevates CDK4, a cell cycle progression factor
pp. 106-106(1)
Authors: Gill J.H.; Dive C.; Roberts R.A.

Interleukin-2 counteracts cytolytic effects of glucocorticoids on lymphoid cells
pp. 106-106(1)
Authors: Biola A.; Hache G.; Pallardy M.

Evidence of apoptosis in tacrine cell death
pp. 106-106(1)
Authors: Debbasch C.; Osseni R.A.; Rat P.; Christen M.O.; Thevenin M.; Adolphe M.; Warnet J.-M.

Pentachlorophenol-induced apoptosis is related to the inhibition of GAP junctional intercellular communication through p53-dependent manner
pp. 106-107(2)
Authors: Kang K.-S.; Sai K.; Inoue T.

Induction of apoptosis and suppression of phorbol ester-induced activation of NF-B in HL-60 cells by diarylheptanoids structurally related to curcumin
pp. 107-107(1)
Authors: Kang J.-Y.; Lee E.; Lee J.-M.; Chun K.-S.; Kim O.H.; Surh Y.-J.

Fluoride-induced apoptosis and necrosis in a human lung epithelial cell line: involvement of PKA-and PKC-mediated mechanisms
pp. 107-107(1)
Authors: Refsnes M.; Lag M.; Skuland T.; Samuelsen J.; Schwarze P.

Bax expression and apoptosis in epithelial rat lung cells exposed to cadmium
pp. 107-107(1)
Authors: Lag M.; Bjornsrud C.; Lerstad T.; Lilleaas E.; Schwarze P.E.; Refsnes M.

Possible role for FAS (CD95) activity in cyclosporin (CsA)-induced apoptosis in LLC-PK1 cells
pp. 108-108(1)
Authors: Dempsey M.; Healy E.; Ryan M.P.

Implications of the proteins p53, C-MYC and BCL-2 in apoptosis of hepatocarcinoma cell lines transfected with antisense IGF-I cDNA
pp. 108-108(1)
Authors: De Oliveira G.A.; Ellouk-Achard S.; Desauty G.; Sarasin A.; Lafarge-Frayssinet C.

BCL-2 and BCL-XL inhibit antidepressant-induced apoptosis
pp. 108-108(1)
Authors: Xia Z.; DePierre J.W.; Nassberger L.

Role of caspase-3 in apoptosis induced by glucocorticoids on lymphoid cells
pp. 108-108(1)
Authors: Hache G.; Biola A.; Pallardy M.

Action of ethylene glycol monomethyl ether and its metabolite 2-methoxyacetaldehyde on ornithine decarboxylase, apoptosis and syrian hamster embryo cell transformation frequency
pp. 109-109(1)
Authors: Dhalluin S.; Elias Z.; Poirot O.; Gate L.; Paul J.; Tapiero H.; Pages N.; Rast C.; Vasseur P.; Nguyen-Ba G.

Apoptosis in the hypoxia-induced cell damage
pp. 109-109(1)
Authors: Voicu V.A.; Hinescu M.E.; Alexandrescu R.; Marculescu Z.; Jiquidi M.; Pociu A.

Trimethyltin but not triethyltin induces specific neural cell death through the protein stannin
pp. 109-109(1)
Authors: Viviani B.; Galli C.L.; Marinovich M.

Ethanol interferes with the trophic action of NMDA and carbachol, but not with that of forskolin and GABA, on cultured cerebellar granule neurons undergoing apoptosis
pp. 109-110(2)
Authors: Castoldi A.F.; Barni S.; Costa L.G.; Manzo L.

Tiazofurin induces apoptosis in C6 rat glioma cells
pp. 110-110(1)
Authors: Vracar M.; Piperski V.; Jovanovic S.; Jokanovic M.; Rakic L.

Studies on genotoxicity and apoptosis induced by extracts of Tripterygium Hypoglaucum
pp. 110-110(1)
Authors: Cao J.; Nusse M.; Yang M.J.

In vitro evaluation of the myelosuppressive potential of the atrazine herbicide and its metabolites on human hematopoietic cells
pp. 110-110(1)
Authors: Sawicki B.; Durand G.; Choucroun P.; Dewitte J.D.; Leglise M.C.

Development of a quantitative method for the analysis of 3-nitrotyrosine in small amounts of proteins
pp. 110-111(2)
Authors: Herce-Pagliai C.; Kotecha S.; Shuker D.E.G.

The effect of N^G-nitro-L-arginine methyl ester on latex particle uptake in the rat intestine
pp. 111-111(1)
Authors: Hashimoto K.; Limpanussorn J.; Noel C.; Simon L.; Dayan A.D.

Effects of NMDA receptor and nitric oxide on methamphetamine-induced neurotoxicity
pp. 111-111(1)
Authors: Cho D.H.; Park C.W.; Kim J.G.; Lee Y.S.; Seo K.W.; Moon H.H.; Cho M.H.

Effect of low-level lead acetate exposure on nitric oxide synthase activity in capillary and synaptosomal fractions of mice brain
pp. 111-111(1)
Authors: Garcia-Arenas G.; Claudio L.; Galvan-Arzate S.; Rios C.

NO is not involved in LPS repression of CYP2B1 MRNA in primary rat hepatocytes
pp. 111-112(2)
Authors: Ferrari L.; Morgan E.T.

Studies on the effect of carbon disulfide on nitric oxide and lipid peroxidation
pp. 112-112(1)
Authors: Wen-chang Z.; Li-qing T.

Streptomyces anulatus induced production of nitric oxide and cytotoxicity in human alveolar type 11 epithelial cells (A549)
pp. 112-112(1)
Authors: Hirvonen M.-R.; Jussila J.; Ruotsalainen M.; Savolainen K.; Nevalainen A.

Areca nut extracts stimulate DNA strand breaks by generation of nitric oxide
pp. 112-112(1)
Authors: Liu T.Y.; Chi C.W.

No production in a undifferentiated and differentiated human intestinal cell line
pp. 112-112(1)
Authors: Vignoli A.L.; Zucco F.; Stammati A.; Srivastava R.C.

Prostaglandin E₂ synthesis affected by nitric oxide in macrophages
pp. 112-113(2)
Authors: Guastadisegni C.; Balduzzi M.; Minghetti L.; Nicolini A.; Polazzi E.

The role of tumor necrosis factor- and nitric oxide in acute liver injury induced by carbon tetrachloride
pp. 113-113(1)
Authors: Morio L.A.; Laskin D.L.

Mice lacking inducible nitric oxide synthase are protected from acetaminophen-induced hepato-toxicity
pp. 113-113(1)
Authors: Laskin J.D.; Gardner C.R.; Heck D.E.; Chiu H.; Durham S.K.; Laskin D.L.

The role of nitric oxide on lead nephrotoxicity in perfused rat kidney
pp. 113-113(1)
Authors: Ghazi-Khansari M.; Ala S.; Essalat M.; Dehpour A.R.

Anticarcinogenesis and antiinflammation of (-)-epigallocatechin-3-gallate through modulating the induction of nitric oxide synthase
pp. 114-114(1)
Authors: Lin J.-K.; Lin Y.-L.; Lin-Shiau S.-Y.

The relationship between antioxidant status and nitric oxide in type II diabetic patients
pp. 114-114(1)
Authors: Aydin A.; Orhan H.; Sayal A.; Ozata M.; Sahin G.; Isimer A.

Role of nitric oxide (NO) in IDPN-induced neuro-behavioral and vestibular toxicity
pp. 114-114(1)
Authors: Tariq M.; Khan H.A.; Al Moutaery K.; Al Deeb S.

Acute toxicity assessment in Sprague-Dawley rats after administering the Neisseria meningitidis-P64k recombinant protein. Intramuscular administration
pp. 114-114(1)
Authors: Alvarez S.; Berlanga J.; Silva R.; Rodriguez S.; Marrero G.; Valenzuela C.; Castaneda J.M.; Sam S.

Neurotoxic effects of tiazofurin in the rat are not caused by interaction with cholinesterases
pp. 115-115(1)
Authors: Jokanovic M.; Piperski V.; Maksimovic M.; Maksimovic M.; Kilibarda V.; Jovanovic S.; Rakic L.

Effects of S 14292, a new anti-osteoporotic agent, on rat colic mesenteric lymph nodes: a toxicologic and toxicokinetic approach
pp. 115-115(1)
Authors: Blot C.; Gordon B.; Boivin J.-F.; Bertheux H.; de Conchard G.V.; Goldfain-Blanc F.; Descotes G.

Effects of chronic lithium on ototoxicity induced by gentamicin and amikacin in guiea pig
pp. 115-115(1)
Authors: Sharifzadeh M.; Behrooz H.; Rezvani M.

Subchronic toxicity of amoksiklav^R
pp. 115-115(1)
Authors: Lavric A.; Culjak K.; Tibaut D.; Nemec M.

Time course of ECG alterations in rats observed after myocardial lesions induced by isoprenaline
pp. 115-116(2)
Authors: Rossiello E.; Mattei E.; Mesiti G.; DeFeo G.; Lisciani R.

Photomutagenesis by terfenadine
pp. 116-116(1)
Authors: Hrelia P.; Brighenti B.; Cantelli Forti G.

Metabolism of dexfenfluramine in vitro is dependent on CYP2D6
pp. 116-116(1)
Authors: Haritos V.S.; Ching M.S.; Ghabrial H.; Gross A.S.; Ahokas J.T.

Preclinical toxicology of biovector^TM nanoparticles: part I, general toxicology
pp. 116-116(1)
Authors: Kravtzoff R.; Loget O.; Manciaux X.; Attia M.; Cholet G.; De Miguel I.; Major M.; Betbeder D.; Forster R.

Preclinical toxicology of biovector^TM nanoparticles: part II, local tolerance, genetic toxicology and pharmacokinetics
pp. 117-117(1)
Authors: Kravtzoff R.; Appelqvist T.; Haddouk H.; Manciaux X.; Cholet G.; De Miguel I.; Major M.; Betbeder D.; Forster R.

Toxicological studies on the pharmaceutical excipient aquateric⁽R) aqueous enteric coating
pp. 117-117(1)
Authors: Kotkoskie L.A.; Batt K.J.; Freeman C.; Palmieri M.A.

A new genomic approach to monitor toxicity of candidate compounds for development
pp. 117-117(1)
Author: Schweighoffer

Effect of potential antioxidants on model of chronic colitis in rats
pp. 117-117(1)
Authors: Stetinova V.; Grossmann V.

Carcinogenesis of ebrotidine in rat
pp. 117-118(2)
Authors: Romero A.; Grau T.; Villamayor F.

Intracellular drug storage disorders in rats and monkeys induced by a new anti-diabetic agent
pp. 118-118(1)
Authors: Goldfain-Blanc F.; de Conchard G.V.; Bertheux H.; Lhote N.; Blot C.; Lorge E.; Descotes G.

Repeated dose 14-day and 90-day oral toxicity studies in beagle dogs with the compound GYKI 16084
pp. 118-118(1)
Authors: Kiss E.; Druga A.; Meggyesy K.; Mikos A.

HMG-CoA reductase activity in human liver microsomes: compared vastatins inhibitions
pp. 118-118(1)
Authors: Dansette P.M.; Jaouen M.; Pons C.

A study on the possible protective and curative effects of ketotifen, nigella sativa oil, allo-purinol with dimethyl sulphoxide and prednisolone on trinitrobenzene sulphonic acid induced colitis in rats
pp. 118-119(2)
Authors: Shalouh Z.A.; Arab A.M.; El-Medany A.M.H.; Moursi M.G.; Borakat M.K.; Hassan I.E.

Experimental study of the zeolit-Cu_x-cyclophosphamide system
pp. 119-119(1)
Authors: Dinu E.; Andronescu E.; Naghi E.; Cojocaru M.

Formulation of insoluble test substances for long term oral administration in toxicology investigations
pp. 119-119(1)
Authors: Smith T.; Kelly J.

Safety pharmacological studies of drugs
pp. 119-119(1)
Authors: Vertes K.; Kovacs M.; Sebestyen G.

Mechanisms of neurotoxicity of substituted amphetamines
pp. 119-119(1)
Authors: Laverty R.; Russell B.R.; Zheng Y.

Ephedrone - new street drug synthetized from proasthmin
pp. 120-120(1)
Authors: Janowska E.; Chudzikiewicz E.; Lechowicz W.

Hallucinogen bannisteriopsis CAAPI: use in religious sects, abuse and chromatographic identification
pp. 120-120(1)
Authors: Khon L.K.; Carvalho J.E.; Cazenave S.O.S.

Screening of oestrogen and progesterone interference with morphine identification in 24 hr urine by TLC technique
pp. 120-120(1)
Authors: Sabzevari O.; Ebrahimi K.; Karimi G.R.

Efficiency of cedia dau sample check assay for the detection of urine adulterations
pp. 120-121(2)
Authors: Coudore F.; Guyon M.

Analysis of cocaine and its two active metabolites in biological samples by HPLC with photodiode array detection for toxicological studies
pp. 121-121(1)
Authors: Foulon C.; Menet M.-C.; Pham-Huy C.; Sandouk P.; Scherrmann J.-M.; Galons H.; Guyon F.; Claude J.-R.

Sexual abuse, clinical diseases, drug/alcohol dependence and other mental disorders: a cross-cultural review
pp. 121-121(1)
Authors: Villanassi R.; Tarello L.G.; Camiza L.D.; Kerr-Correa F.

Dynamics of the drug abuse during last decade (1987-1997) in Estonia
pp. 121-121(1)
Author: Raudsepp R.

Drugs consumption in aids patients under hospital care
pp. 121-121(1)
Authors: Duenas-Laita A.; Pinacho-Pelaez F.; Freijanes N.; Bachiller P.; Martinez-Barrero M.

Unsanctioned use of therapeutic drugs
pp. 122-122(1)
Authors: Cazenave S.O.S.; Correa C.L.; Freitas E.C.; Matias L.

Acute poisonings with psychoactive drugs among the abusers of Krakow adult population
pp. 122-122(1)
Authors: Gawlikowski T.; Pach J.; Targosz D.; Motyka E.; Szkolnicka B.

Chronic toxicity of propoxypirin
pp. 122-122(1)
Authors: Lishan P.; Shen S.; Beng X.; Changping L.; Jiwang Z.

Autonomic dysfunction in manganese (Mn) alloy workers
pp. 122-123(2)
Authors: Angle C.R.; Barrington W.W.; Willcockson N.K.; Padula M.A.

Oxidative stress: a neurochemical mechanism of manganese-induced neurotoxicity
pp. 123-123(1)
Authors: Ali S.F.; Duhart H.M.; Lipe G.W.; Newport G.D.; Slikker W.

Uptake and transport of cadmium by CACO-2 cells
pp. 123-123(1)
Authors: Lecoeur S.; Blais A.; Kolf-Clauw M.; Huneau J.F.; Milhaud G.; Tome D.

Toxicokinetics of cadmium in lactating ewes: effects of a calcium dietary supplement
pp. 123-123(1)
Authors: Enriquez B.; Houpert P.; Benm'rah N.; Milhaud G.

Histopathological changes in three brain regions of rats after perinatal combined exposure to cadmium and dexametasone
pp. 124-124(1)
Authors: Mendez-Armenta M.; Barroso-Moguel R.; Villeda-Hernandez J.; Romero-Diaz V.; Osorio Rico L.; Rios C.

Dietary intake of cadmium in selected volunteers living in Bangkok and Rural Thailand
pp. 124-124(1)
Authors: Srianujata S.; Chunhabandit R.; Suphanithasnaporn B.

The influence of cadmium on serum iron binding capacity
pp. 124-124(1)
Authors: Moniuszko-Jakoniuk J.; Jurczuk M.; Kowalczyk M.

The influence of the physical effort on the lyzosomal enzymes activity in the cadmium acetate intoxicted rats tissues
pp. 124-124(1)
Authors: Bakonska-Pacon E.; Milnerowicz H.; Sobiech K.A.

Metallothionein as biomarker of cadmium exposition: Part I. The influence of the oxygen-ozone mixture injections and the physical effort on the both cadmium and metallothionein accumulation in the cadmium intoxicated rats tissues
pp. 125-125(1)
Authors: Milnerowicz H.; Bakonska-Pacon E.; Sobiech K.A.

Metallothionein-biomarker of Cd exposition. Part II: Immunohistochemical localization of metallothionein in tissues of rats intoxicated with cadmium acetate and subjected to peritoneal oxygen-ozone injections
pp. 125-125(1)
Authors: Milnerowicz H.; Madej J.

Chronic alternate or daily cadmium exposure differentially affect its accumulation within the tissues. Effects of age
pp. 125-125(1)
Authors: Marquez N.; Alvarez-Demanuel E.; Piquero S.; Esquifino A.I.; Lafuente A.

Acute versus subchronic exposure to cadmium differentially affects the pulsatile secretion pattern of prolactin in adult male rats
pp. 125-126(2)
Authors: Alvarez-Demanuel E.; Esquifino A.I.; Marquez N.; Castrillon P.O.; Lafuente A.

Subchronic cadmium exposure differentially affects the pulsatile secretory pattern of LH in young compared to adult male rats
pp. 126-126(1)
Authors: Lafuente A.; Marquez N.; Alvarez-Demanuel E.; Piquero S.; Esquifino A.I.

Amphipathic dithiocarbamate induced intra cellular cadmium mobilization and modulation of metallothionein
pp. 126-126(1)
Authors: Agarwal D.K.; Tandon S.K.

The constructive metabolism staphylococcus aureus containing plasmids of resistance to a number of antibiotics and Cd²⁺
pp. 126-126(1)
Authors: Kozitskaya S.N.; Vinnikov A.I.

Effects of cadmium on the expression of PCNA and c-myc in mouse embryo limb bud cell
pp. 126-126(1)
Authors: Yang L.; Shusen Z.; Shufen Z.

Distribution of lead in the pregnant swine model
pp. 127-127(1)
Authors: Casteel S.W.; Brown L.D.; Cowart R.P.; Turk J.R.; May T.W.; Hoffman E.; Henningsen G.M.; Weis C.P.

In vitro effects of lead acetate on human erythroblastic progenitors
pp. 127-127(1)
Authors: Boucher A.; Rio B.; Guinard-Flament J.; Parent-Massin D.

Low level lead exposure and central dopaminergic mechanisms
pp. 127-127(1)
Author: Jadhav A.L.

Effects of acute and chronic lead acetate pretreatment on chlorpromazine induced catalepsy in mice
pp. 127-127(1)
Authors: Sharifzadeh M.; Djandaghi G.H.; Khorasani R.; Alvandi Z.

Changes in hepatic metabolism due to gestational and lactational administration of lead
pp. 128-128(1)
Authors: Benito M.J.; Corpas I.; Antonio M.T.

Renal alterations induced by lead administration during gestational and lactational period
pp. 128-128(1)
Authors: Benito M.J.; Antonio M.T.; Corpas I.

The modification of blood calcium and blood magnesium in the professional exposure to lead
pp. 128-128(1)
Authors: Fat L.; Coldea V.

Lead-induced impairment of LTP in hippocampal DG and antagonistic role of zinc
pp. 128-128(1)
Authors: Ruan D.-Y.; Chen J.; Zhao Y.; Xu Y.-Z.

Nanomolar concentrations of Pb²⁺ increase spontaneous and block evoked transmitter release in hippocampal neurons
pp. 129-129(1)
Authors: Braga M.F.M.; Albuquerque E.X.; Pereira E.F.R.

The role of glutamatergic neuronal stimulation and oxidative stress in lead neurotoxicity
pp. 129-129(1)
Authors: Loikkanen J.; Naarala J.; Savolainen K.

Lead concentration in peripheral tissues after seven-month implantation in the rat brain of lead solid sphere or fragments
pp. 129-129(1)
Authors: Vassilieff I.; Godinho A.F.; Silva-Junior B.A.; Homi M.; Moreira E.G.; Jy J.H.; Vassilieff V.S.

Childhood lead survey program in Thailand
pp. 129-130(2)
Authors: Pavittranon S.; Teeyapant P.; Muangnoicharoen N.

DL-methionine, L-cysteine and N-acetyl-L-cysteine are efficient chelating agents for sub-chronic lead intoxication
pp. 130-130(1)
Authors: Almeida A.A.; Vassilieff V.S.; Vassilieff I.

Influence of meso 2,3-dimercaptosuccinic acid and/or EDTA on lead mobilization and redistribution in lead-exposed albino rats
pp. 130-130(1)
Authors: Sharkawy A.A.; Abd-El ghaffar S.K.; Zakhary M.M.

Effect of tissue binding uncertainty on a PBTK model of methylmercury in the fetal rat
pp. 130-130(1)
Authors: Lewandowski T.A.; Bartell S.M.; Pierce C.H.; Ponce R.A.; Faustman E.M.

The analysis of cuprum and mercury combinations with L-ascorbic acid dependent on the level of metal oxidation
pp. 130-131(2)
Authors: Kleszczewska E.; Kozakiewicz H.

Mercury intoxication: surgical treatment of a case
pp. 131-131(1)
Authors: Vieira R.J.; Zambrone F.A.D.; De Capitani E.M.; Nunes P.H.F.; Bucaretchi F.; Madureira P.R.

Mercury Intravascular Injection
pp. 131-131(1)
Authors: Mimieux I.; Allanic C.; Dally S.

Mercury exposure in gold mine workers
pp. 131-131(1)
Authors: Mattos S.V.M.; Werneck G.A.F.; Sa W.R.; Hermeto M.; Prado G.; Correa E.C.

Comparative analyses of exposure estimates based on biomarkers or predictive models: a case example with dietary methylmercury intake
pp. 131-132(2)
Authors: Ponce R.A.; Bartell S.M.; Sanga R.N.; Faustman E.M.

Cortical mercury concentration in neonatal rats after continued transplacental exposure
pp. 132-132(1)
Authors: De Visscher G.; Joiris C.; Vilagi I.; Szente M.; Kirsch-Volders M.

Role of mitochondria in biotransformation of methylmercury
pp. 132-132(1)
Authors: Hirayama K.; Yasutake A.; Mori N.; Inouye M.

Methylmercury-induced increase in intracellular calcium level of dissociated rat cerebellar granule cells
pp. 132-132(1)
Authors: Sakamoto M.; Nakano A.; Adachi T.

Pre-exposure to inorganic mercury delays toxicity to methyl mercury chloride in the spinal chord neuron X neuroblastoma hybrid cell line (NSC-34)
pp. 132-133(2)
Authors: Chapman L.A.; Chan H.M.

Behavioral manifestations of prolonged mercury exposure in rats
pp. 133-133(1)
Authors: Almeida A.A.; Curti C.A.; Vassilieff V.S.; Vassilieff I.

In vitro study of mercury vapor release from dental amalgams
pp. 133-133(1)
Authors: Livardjani F.; Jahanbakht S.; Schlegel A.; Haikel Y.; Jaeger A.; Lugnier A.

Urinary mercury concentration in children under local and general anaesthesia after placing amalgam restorations
pp. 133-133(1)
Authors: Livardjani F.; Jahanbakht S.; Maniere M.C.; Haikel Y.; Jaeger A.; Lugnier A.

Mechanisms of methylmercury-induced cell cycle arrest and cell death in primary embryonic CNS cells
pp. 133-134(2)
Authors: Faustman E.M.; Lu S.; McMillan M.J.; Kirchner S.C.; Ou Y.C.

Influence of mineral drinking water on the cytotoxic effect of radio-mercury exposure with low dose
pp. 134-134(1)
Authors: Ivanov S.D.; Nechiporenko U.Y.; Malov A.M.

Glutathione-dependent biliary excretion of selenium is enhanced paradoxically by sulfobromophthalein
pp. 134-134(1)
Authors: Gyurasics A.; Perjesi P.; Gregus Z.

Selenium status in the blood of students and sea food for recommendation of supplementation in illeness
pp. 134-134(1)
Authors: Sukumar A.; Muhuntha A.; Subramanian R.

Selenite metabolites react in vivo with sulfobromophthalein (BSP) to form cholephilic BSP-Se metabolites
pp. 134-135(2)
Authors: Gregus Z.; Gyurasics A.; Perjesi P.

Arsenic (As³⁺) increases cellular homocysteine (Hcy) in cobalmin (B12) deficient human fibroblasts: a mechanism for nutrient/toxicant interaction
pp. 135-135(1)
Authors: Angle C.R.; Swanson S.A.

Determination of harderoporphyrin a biomarker for arsenic exposure
pp. 135-135(1)
Authors: Ng J.C.; Qi L.; Chiswell B.; Moore M.R.

Bioavailability of arsenic in contaminated media
pp. 135-135(1)
Authors: Casteel S.W.; Brown L.D.; Cowart R.P.; Pace L.W.; Hoffman E.; Henningsen G.M.; Weis C.P.

Is the use of 24 hour urine samples and creatinine adjustment required for analysis of inorganic arsenic in urine in population studies?
pp. 135-136(2)
Authors: Sim M.R.; Hinwood A.L.; Jolley D.J.; Bastone E.B.; McNeil J.J.

Toxicokinetics of arsenic after single doses of arsenic trioxide in rats
pp. 136-136(1)
Author: Juruli M.

The oral toxicity and mutagenicity of antimony trioxide
pp. 136-136(1)
Authors: Veenstra G.E.; Deyo J.; Penman M.

Risk assessment for the exposure to antimony compounds
pp. 136-136(1)
Authors: Veenstra G.E.; Deyo J.; Penman M.

Comparative ameliorative efficacy of in organic salts for fluoride ions, studied in goats with toxico-kinetic model
pp. 136-137(2)
Authors: Chandra S.; Gupta P.K.; Singh Y.P.; Vijjan V.K.

Zinc oxide enhancement of chemiluminescence in rat neutrophils
pp. 137-137(1)
Authors: Ogino K.; Hiramatsu T.; Inagaki M.; Nagase H.; Nakamura H.; Okuda M.; Houbara T.

Induction of metallothionein by antioxidants - a possible protective mechanism against metal toxicity
pp. 137-137(1)
Author: Rana S.V.S.

Acute thallium poisoning and its treatment with two cases report
pp. 137-137(1)
Authors: Zhao J.-y.; Xu X.-x.; Mao L.-j.

Urinary nickel as bioindicator of Ni exposure of workers in a galvanizing plant in Brazil
pp. 137-137(1)
Authors: Siqueira M.E.P.B.; Oliveira J.P.

The influence of cupric ions on contractile activity of the humans uterus in vitro
pp. 138-138(1)
Authors: Kleszczewska E.; Kostrzewska A.; Modzelewska B.; Kleszczewski T.

Cytotoxicity and intracellular behaviour of uranium (VI) on LLC-PK₁ cells: influence of uranium speciation
pp. 138-138(1)
Authors: Mirto H.; Barrouillet M.P.; Henge-Napoli M.H.; Fournier M.; Cambar J.

Uranium (VI) complexation with blood components using capillary electrophoresis: first results and perspectives for toxicological evaluation
pp. 138-138(1)
Authors: Scapolan S.; Hemidy P.Y.; Ansoborlo E.; Moulin C.; Metivier H.; Madic C.

Zinc supplementation of chelation therapy in saturnism - preliminary study
pp. 138-138(1)
Authors: Badulici S.-C.; Chirila M.

Treatment with zincum metallicum CH₅ in patients with liver cirrhosis - preliminary study
pp. 138-139(2)
Authors: Badulici S.-C.; Chirulescu Z.; Chirila P.; Chirila M.; Rosca A.

Metal chelation by keratin in scale & hair
pp. 139-139(1)
Authors: Coello W.F.; Khan M.A.Q.

Estimation of toxic influence of heavy metals in industrial objects
pp. 139-139(1)
Authors: Remez I.; Baumane M.; Rabkin L.; Andersons P.

Occupational exposure to lead
pp. 139-139(1)
Authors: Antunes I.; de Albuquerque M.; Pereira L.; Vieira D.N.; Marques E.G.P.; Monsanto P.V.; Avila M.T.

Cytotoxicity of organophosphate anticholinesterases to human liver and nerve cells
pp. 140-140(1)
Authors: Mioduszewski R.J.; Menking D.E.; Valdes J.J.; Cao C.J.; Eldefrawi M.E.; Eldefrawi A.T.

Toxicokinetics of glufosinate, an herbicide structurally analogous to glutamic acid, that causes severe CNS disorders in human acute oral poisoning
pp. 140-140(1)
Authors: Koyama K.; Kohda Y.; Hisashi H.; Koyama K.; Goto K.

Health surveillance study in the workers of the agricultural field, exposed to combination of pesticides in Barpeta Dist., Assam, India
pp. 140-140(1)
Author: Hazarika R.

Carcinogenic risk characterization for folpet
pp. 140-140(1)
Author: Gordon E.B.

Carcinogenic risk characterization for captan
pp. 141-141(1)
Authors: Gordon E.B.; Mobley S.A.; Elliott B.

Pesticide exposure in a farming village in a developing country
pp. 141-141(1)
Authors: Rojas M.; Reid J.; Rivero E.; Rincon R.

The implication of nitrites and organochlorine pesticides on iodine metabolism to schoolchildren on Iassy City
pp. 141-141(1)
Authors: Hura C.; Leanca M.; Palamaru I.; Rusu L.

Human exposure at chemical pollutants risk for the public health
pp. 141-141(1)
Authors: Hura C.; Leanca M.; Palamaru I.; Rusu L.

Arylesterase and paraoxonase enzymes activity in adult in City of Kashan
pp. 141-142(2)
Authors: Ghazi-Khansari M.; Alvani S.; Samadi A.

Characteristics of respiratory disorders in acute poisoning with organophosphorous insecticides
pp. 142-142(1)
Author: Bosan-Kilibarda I.

Forbidden rodenticide leading to increasing death rates in Brazil
pp. 142-142(1)
Authors: Caldas L.Q.A.; Unes A.F.

In vitro effects of two pesticides on human erythroblastic progenitors
pp. 142-142(1)
Authors: Parent-Massin D.; Rio B.; Guinard-Flament J.; Boucher A.

Effects of diphenyl-ether herbicides on human erythropoiesis in vitro
pp. 142-143(2)
Authors: Rio B.; Guinard-Flament J.; Boucher A.; Parent-Massin D.

Toxicokinetic of bifenox in goats after single dose oral administration
pp. 143-143(1)
Authors: Mandal T.K.; Roy S.; Chakraborty A.K.; Bhattacharyya A.; Chowdhury A.